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Medical	imaging	has	enormous	potential	for	early	disease	prediction,	but	is	impeded	by	the	difficulty	and	25	
expense	of	acquiring	datasets	prior	to	symptom	onset.	UK	Biobank	aims	to	address	this	problem	directly	26	
by	 acquiring	 high	 quality,	 consistently	 acquired	 imaging	 data	 from	 100,000	 predominantly	 healthy	27	
participants,	with	health	outcomes	tracked	over	coming	decades.	The	brain	imaging	includes	structural,	28	
diffusion	and	 functional	modalities.	Along	with	body	and	cardiac	 imaging,	 genetics,	 lifestyle	measures,	29	
biological	phenotyping	and	health	records,	this	is	expected	to	enable	discovery	of	imaging	markers	of	a	30	
broad	 range	 of	 diseases	 at	 their	 earliest	 stages,	 as	 well	 as	 provide	 unique	 insight	 into	 disease	31	
mechanisms.	We	describe	UK	Biobank	brain	 imaging,	 and	present	 results	derived	 from	 the	 first	5,000	32	
participants’	data	 release.	Although	 that	 covers	 just	5%	of	 the	ultimate	 cohort,	 it	 already	yields	a	 rich	33	
range	of	associations	between	brain	imaging	and	other	measures	collected	by	UK	Biobank.		34	 	35	 The	primary	clinical	role	of	brain	imaging	to	date	has	been	in	diagnosis	and	monitoring	of	disease	progression,	36	 rather	 than	providing	predictive	markers	 for	preventative	 stratification	or	 early	 therapeutic	 intervention.	The	37	 predominant	 strategy	 for	 finding	 image-based	 markers	 of	 neurological	 and	 psychiatric	 disease	 has	 been	 to	38	 identify	patients	early	in	the	diagnostic	process	to	maximize	statistical	power	in	a	small	cohort	(tens	to	hundreds	39	 of	 subjects).	 A	 key	 factor	 motivating	 the	 use	 of	 small,	 clinically-defined	 cohorts	 is	 the	 expense,	 time	 and	40	 specialized	hardware	associated	with	imaging.	This	approach	has	been	effective	in	providing	markers	of	disease	41	 progression,	 but	 identifying	 imaging	markers	of	 early	disease	 requires	measurements	 at	 the	pre-symptomatic	42	 stage.	Image-based	measures	of	brain	structure	and	function	may	evolve	in	a	complex	way	throughout	aging	and	43	 progression	 of	 neuropathology.	 Therefore,	 markers	 with	 utility	 in	 monitoring	 disease	 progression	 post-44	 diagnostically	 may	 not	 manifest	 pre-symptomatically,	 and	 conversely	 the	 most	 sensitive	 early	 predictors	 of	45	 disease	may	have	plateaued	by	the	time	existing	diagnoses	become	accurate.	46	 Nevertheless,	when	 known	 risk	 factors	 have	 enabled	 risk-stratified	 cohorts,	 imaging	 has	 been	 able	 to	 predict	47	 disease	 before	 symptom	 presentation.	 For	 example,	 magnetic	 resonance	 imaging	 (MRI)	 has	 demonstrated	48	 altered	 brain	 activity	 associated	 with	 the	 APOE	 genotype	 decades	 in	 advance	 of	 symptoms	 associated	 with	49	 Alzheimer’s	disease1,	and	conversion	from	mild	cognitive	impairment	to	Alzheimer’s	has	been	predicted2.	These	50	 studies	 suggest	 that	 the	 primary	 obstacle	 to	 identifying	 early	 imaging	 markers	 is	 in	 obtaining	 data	 in	 pre-51	 symptomatic	cohorts	drawn	from	the	general	population.	52	 Alternatively,	pre-symptomatic	cohorts	can	be	assembled	using	a	prospective	approach,	in	which	a	large	number	53	 of	 healthy	 participants	 are	 intensively	 phenotyped	 (including	 imaging)	 and	 subsequently	monitored	 for	 long-54	
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term	health	outcomes.	While	 this	 approach	 is	 expensive,	 it	 is	 also	efficient	by	 capturing	early	biomarkers	and	55	 risk	 factors	 for	 a	 broad	 range	 of	 diseases.	 It	 further	 becomes	 possible	 to	 discover	 unexpected	 interactions	56	 between	 risk	 factors	 (such	as	 lifestyle	 and	genetics).	To	date,	 the	 largest	brain	 imaging	 studies	have	gathered	57	 data	 on	 a	 few	 thousand	 subjects.	While	 this	 approach	has	 identified	 associations	between	 imaging	 and	highly	58	 prevalent	 diseases,	 existing	 cohorts	 are	 still	 too	 small	 to	 produce	 sufficient	 incidence	 of	 many	 diseases	 if	59	 participants	are	recruited	without	identifying	risk	factors.		60	 UK	Biobank	is	a	prospective	epidemiological	resource	gathering	extensive	questionnaires,	physical	and	cognitive	61	 measures	 and	 biological	 samples	 (including	 genotyping),	 in	 a	 cohort	 of	 500,000	 participants3.	 Participants	62	 consent	to	access	to	their	full	health	records	from	the	UK	National	Health	Service,	enabling	researchers	to	relate	63	 phenotypic	 measures	 to	 long-term	 health	 outcomes.	 This	 is	 particularly	 powerful	 due	 to	 the	 combination	 of	64	 number	of	subjects	and	breadth	of	linked	data.	Participants	were	40-69	years	of	age	at	baseline	recruitment;	this	65	 aims	 to	 balance	 the	 goals	 of	 characterizing	 subjects	 prior	 to	 disease	 onset	 against	 the	 delay	 before	 health	66	 outcomes	accumulate.	The	cohort	is	particularly	appropriate	for	study	of	age-associated	pathology.	All	data	from	67	 UK	Biobank	are	available	to	researchers	world-wide	upon	application,	with	no	preferential	access	for	scientists	68	 leading	the	study.	An	imaging	extension	to	the	existing	UK	Biobank	study	was	funded	in	2016	to	scan	100,000	69	 subjects	from	the	existing	cohort,	aiming	to	complete	by	2022.	Imaging	includes	MRI	of	the	brain,	heart	and	body,	70	 low-dose	x-ray	bone	and	joint	scans,	and	ultrasound	of	the	carotid	arteries.	Identification	of	disease	risk	factors	71	 should	 increase	 over	 time	 with	 emerging	 clinical	 outcomes.	 For	 example,	 within	 the	 imaged	 cohort,	 1800	72	 participants	are	expected	to	develop	Alzheimer’s	disease	by	2022,	rising	to	6000	by	2027	(diabetes:	8000	rising	73	 to	14,000;	stroke:	1800	to	4000;	Parkinson’s:	1200	to	2800)4.	74	 We	present	example	analytic	approaches	and	studies	that	will	be	enabled	by	UK	Biobank.	Identification	of	novel	75	 imaging	 biomarkers	 of	 disease	 risk	 could	 support	 diagnosis,	 development	 of	 therapeutics,	 and	 assessment	 of	76	 interventions.	The	multi-modal,	multi-organ	 imaging	enables	study	of	 interactions	between	organ	systems,	 for	77	 example,	between	cardiovascular	health	and	dementia.	The	breadth	of	 imaging	makes	this	dataset	valuable	for	78	 multi-systemic	syndromes	such	as	frailty,	accelerated	aging	characterized	by	general	 loss	of	reserves	and	poor	79	 tolerance	to	stressors,	which	indicates	increased	risk	for	a	range	of	conditions	including	dementia5.	This	kind	of	80	 resource	can	also	evince	hypotheses	regarding	causal	mechanisms	of	disease	that	could	be	tested	 in	 follow-up	81	 interventional	studies.	Examples	include	modifiable	risk	factors,	such	as	the	association	of	obesity	with	later	life	82	 cognitive	dysfunction6,	and	 the	ability	 to	study	complex	 interactions	of	 risk	 factors	with	 lifestyle,	environment	83	 and	genetics.	Finally,	UK	Biobank	will	enable	validation	and	extension	of	associations	identified	by	smaller-scale	84	 studies,	including	testing	of	hypotheses	that	combine	results	from	multiple	previous	studies.	85	
	86	
RESULTS	87	
Design	rationale	and	initial	imaging	phase	88	 The	imaging	study	was	designed	to	achieve	the	target	of	100,000	subjects,	each	scanned	once,	over	5-6	years	at	89	 three	 dedicated,	 identical	 centers	 operating	 7	 days/week,	 each	 scanning	 18	 subjects/day7.	 This	 places	 tight	90	 timing	 constraints,	 corresponding	 to	 one	 subject	 imaged	 every	 36	 minutes	 (see	 Online	 Methods).	 The	 first	91	 imaging	center	was	built	 to	establish	 feasibility	and	scanned	10,000	subjects	over	a	 two-year	ramp-up	period.	92	 Two	 further	 identical	 centers	 are	 being	 commissioned,	 with	 the	 three	 centers	 strategically	 positioned	 at	93	 population	hubs:	Manchester,	Reading	and	Newcastle.	94	 The	 goal	 of	 capturing	 imaging	 phenotypes	 relevant	 to	 the	 widest	 possible	 range	 of	 diseases	 and	 hypotheses	95	 meant	 that	 the	protocol	must	deliver	data	with	 the	broadest	predictive	power	 for	neuropathology	and	mental	96	 health.	 We	 therefore	 included	modalities	 that	 drive	 estimates	 of	 anatomical	 and	 neuropathological	 structure	97	 (“structural	MRI”),	 brain	 activity	 (“functional	MRI”,	 or	 fMRI),	 and	 local	 tissue	microstructure	 (“diffusion	MRI”,	98	 dMRI).	 The	 resulting	 imaging	 protocol	 (Supplementary	 Table	 1)	 included:	 three	 structural	 modalities,	 T1-99	 weighted,	T2-weighted	and	susceptibility-weighted	MRI	(referred	to	here	as	T1,	T2	and	swMRI);	dMRI;	and	both	100	 task	and	resting-state	functional	MRI	(tfMRI	and	rfMRI).	Recent	advances	in	MRI	acquisition	technology8	enabled	101	 high	 spatial	 resolution	 dMRI	 and	 fMRI	with	 high	 angular	 and	 temporal	 resolution,	 respectively,	 despite	 strict	102	 time	constraints.	For	example,	the	protocol	acquires	dMRI	data	with	100	diffusion-encoding	directions	over	two	103	 shells	in	just	7	minutes,	enabling	advanced	model	fitting	of	microstructural	parameters	that	would	not	have	been	104	 possible	 under	 these	 time	 constraints	 with	 previous	 generation	 technology.	 Following	 optimization	 of	105	 acquisition	protocols,	streamlining	of	participant	preparation	and	minimization	of	scanner	dead	time	(see	Online	106	 Methods),	UK	Biobank	was	able	to	incorporate	six	neuroimaging	modalities	in	just	36	minutes.	107	 Unlike	most	of	 the	measurements	 included	in	the	original	UK	Biobank	resource	(e.g.,	alcohol	consumption	and	108	 cognitive	 test	 scores),	 raw	 imaging	data	 is	not	a	directly	useful	 source	of	 information.	 In	addition	 to	requiring	109	 image	 processing	 to	 remove	 artefacts	 and	 align	 images	 across	modalities	 and	 individuals,	 most	 useful	 image	110	
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phenotypes	are	derived	through	complex	calculations	combining	many	voxels	and/or	images.	A	fully	automated	111	 processing	 pipeline	 was	 developed,	 producing	 both	 processed	 images	 as	 well	 as	 image-derived	 phenotypes	112	 (IDPs)	–	currently	2501	distinct	individual	measures	of	brain	structure	and	function.	Example	IDPs	include:	the	113	 volume	of	 specific	brain	structures;	 the	strength	of	 connectivity	between	pairs	of	brain	regions;	 the	estimated	114	 dispersion	 of	 fibers	 in	 a	 given	 white	 matter	 tract.	 IDPs	 are	 intended	 to	 be	 useful	 for	 non-imaging	 experts;	115	 however,	understanding	of	the	confounds	and	pitfalls	of	imaging	is	required	to	draw	appropriate	conclusions.	116	 We	present	 results	 from	 the	 first	data	 release	 (biobank.ctsu.ox.ac.uk/crystal/label.cgi?id=100),	which	 includes	117	 outputs	from	the	processing	pipeline	for	5285	subjects	scanned	in	2014-2015.	As	determined	by	the	processing	118	 pipeline,	98%	of	participants’	datasets	resulted	in	a	usable	T1,	which	is	crucial	 for	deriving	usable	information	119	 from	the	other	modalities.	Of	these,	data	for	the	other	brain	imaging	modalities	were	suitable	for	processing	in	120	 the	 following	 percentages	 of	 subjects:	 T2=97%,	 swMRI=93%,	 dMRI=95%,	 tfMRI=92%,	 	 rfMRI=95%.	 	 All	121	 modalities	were	acquired	and	usable	in	89%	of	subjects.	Results	from	this	data	release	are	illustrated	in	Figs	1-4,	122	 including	a	multimodal	atlas	(separate	population-average	images	for	each	of	the	modalities,	all	aligned	to	each	123	 other),	 available	 for	 download	 and	 online	 browsing	 (www.fmrib.ox.ac.uk/ukbiobank).	 Below,	 we	 present	 the	124	 following	analyses:	voxel-by-voxel	analyses	of	age	effects;	pair-wise	correlations	of	brain	IDPs	with	other	subject	125	 measures;	multivariate	analysis	identifying	dominant	population	patterns	linking	brain	IDPs	to	other	measured	126	 parameters;	and	an	exemplar	hypothesis-led	study	of	aging,	body	mass	index	and	smoking.	127	
	128	
Imaging	data,	atlases	and	imaging-derived	phenotypes	129	 The	 three	 structural	 modalities	 (Fig	 1)	 provide	 information	 about	 different	 aspects	 of	 the	 brain’s	 tissues,	130	 structures	 and	 neuropathologies.	 Data	 quality	 at	 the	 single-subject	 level	 is	 illustrated	 in	Fig	1a,b.	 The	 group-131	 averaged	images	produced	for	each	modality	are	included	in	the	initial	data	release	as	high-quality	atlases	(Fig	132	
1c-f),	depicting	strong	tissue	contrast	and	excellent	 fidelity	of	alignment	across	subjects.	The	T1	modality	(Fig	133	
1a,c)	 is	 the	most	 informative	about	 the	basic	structure	of	 the	brain,	 including	 the	depiction	of	 the	main	 tissue	134	 types	(gray	and	white	matter)	and	gross	structure	of	the	brain	(main	anatomical	landmarks).	From	the	T1	data,	135	 we	derived	25	volumetric	IDPs:	total	tissue	volumes	(gray,	white	and	ventricular	cerebro-spinal	fluid),	and	the	136	 volumes	of	subcortical	gray	matter	structures	such	as	thalamus,	caudate,	putamen,	pallidum,	hippocampus	and	137	 amygdala.	 The	T1	 data	 and	T1-derived	 IDPs	 provide	 sensitive	markers	 of	 atrophy	 (tissue	 loss),	which	 can	 be	138	 both	global	(e.g.,	thinning	of	the	cortex	in	aging)9	and	local	(e.g.,	reduction	of	hippocampal	volume	in	Alzheimer’s	139	 disease)10.	The	T2	data	(Fig	1b,d)	is	a	FLAIR	(fluid-attenuated	inversion	recovery)	acquisition	that	also	depicts	140	 basic	 anatomy,	 but	 is	 valuable	 primarily	 for	 detection	 of	 focal	 “hyperintensities”	 (i.e.,	 high-signal	 regions)	 in	141	 white	matter.	T2	hyperintensities	represent	white	matter	lesions	that	have	been	associated	with	a	broad	range	142	 of	 neuropathological	 conditions11	 (e.g.,	 small	 vessel	 ischaemic	 disease),	 as	 well	 as	 occurring	 with	 increasing	143	 incidence	 in	 aging	 populations	 without	 (or	 potentially	 before)	 manifestation	 of	 neurological	 symptoms.	 IDPs	144	 relating	to	the	volume	of	these	white	matter	lesions	will	be	included	in	future	data	releases.	swMRI	is	a	flexible	145	 modality	 that	 can	be	processed	 in	multiple	ways,	 each	sensitive	 to	different	 clinically-relevant	properties.	The	146	 first	data	release	 includes	T2*	signal	decay	times	and	enhancement	of	venous	vasculature	using	susceptibility-147	 weighted	image	(SWI)	filtering12	(Fig	1e,f).	swMRI	IDPs	in	the	current	data	release	are	the	median	T2*	in	each	of	148	 14	major	 subcortical	 gray	matter	 structures,	 for	 example	 reflecting	 increased	 iron	 deposition	 associated	with	149	 neurodegeneration13.	150	 Diffusion	MRI	 (Fig	 2)	 reflects	 the	 random	 diffusion	 of	water	molecules,	 which	 is	 affected	 by	 the	microscopic	151	 structure	 of	 tissue14,	 enabling	 us	 to	 infer	 the	 local	 density	 of	 cellular	 compartments	 in	 tissue	 (e.g.	 neurites).	152	 Additionally,	 axon	 bundles	 in	 white	 matter	 create	 an	 orientation	 dependence	 of	 water	 movement	 due	 to	153	 hindrance	of	diffusion	perpendicular	to	the	 long	axis	of	white	matter	tracts,	an	effect	 that	can	be	tracked	from	154	 voxel	 to	 voxel	 (“tractography”)	 to	 derive	 long-range	 white	 matter	 pathways.	 Three	 complementary	 diffusion	155	 models	 were	 fit	 to	 the	 signal	 in	 each	 voxel:	 (i)	 the	 diffusion	 tensor	 model15,	 describing	 the	 signal	156	 phenomenologically	as	 resulting	 from	a	3D	ellipsoid	profile	of	water	displacement;	 (ii)	 the	neurite	orientation	157	 dispersion	 and	 density	 imaging	 (NODDI)	 model16,	 estimating	 microstructural	 properties	 (e.g.,	 neurites	 vs.	158	 extracellular	space);	and	(iii)	 the	ball	&	sticks	model17,	estimating	the	orientation	of	multiple	fiber	populations	159	 within	a	voxel	 for	 tractography.	675	 IDPs	were	extracted,	by	averaging	parameters	estimated	by	 the	 first	 two	160	 models	 over	 75	 different	 white-matter	 tract	 regions	 based	 both	 on	 subject-specific	 tractography18	 and	 from	161	 population-average	white	matter	masks19.	162	 fMRI	reflects	neural	activity	indirectly,	based	on	dynamic	changes	in	blood	oxygenation	and	flow	resulting	from	163	 changes	 in	 neural	 metabolic	 demand20.	 The	 task	 deployed	 in	 tfMRI	 (Fig	 3)	 involves	 matching	 shapes	 and	164	 emotionally	negative	 faces21	and	was	chosen	 to	engage	a	 range	of	neural	 systems,	 from	 low-level	 sensory	and	165	 motor	 to	 perceptual	 (e.g.,	 fusiform)	 and	 emotional	 (e.g.,	 amygdala)	 areas.	 The	 16	 tfMRI	 IDPs	 quantitate	 the	166	 strength	of	brain	activity	 changes	 for	 specific	aspects	of	 the	 task,	 in	 regions	defined	using	 the	group-averaged	167	 activation	maps	 shown,	 in	 three	 task	 conditions.	Resting-state	 fMRI	 (Fig	4)	 identifies	 connected	brain	 regions	168	
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based	on	common	 fluctuations	 in	activity	over	 time	 in	 the	absence	of	an	explicit	 task22.	 Sets	of	voxels	 that	 co-169	 fluctuate	most	strongly	correspond	to	brain	regions,	referred	to	as	network	“nodes”;	different	nodes	may	have	170	 weaker	co-fluctuations	indicating	a	connection	between	them,	a	network	“edge”.	The	group	analysis	of	the	rfMRI	171	 data	generated	two	atlases	of	these	functional	networks	-	a	“low-dimensional”	decomposition	of	the	brain	into	21	172	 functional	 sub-divisions	 and	 a	 higher-dimensional	 parcellation	 into	 55	 sub-divisions.	 IDPs	 represent	 a)	 edge	173	 connectivity	strengths	and	b)	node	fluctuation	amplitudes	(Fig	4).		174	
	175	
Voxel-wise	associations	with	aging	176	 IDPs	reduce	raw	data	into	a	compact	set	of	biologically-meaningful	measures,	with	current	measures	condensing	177	 ~2GB	 raw	 data	 per	 subject	 into	 2501	 IDPs,	 but	 such	 summary	 measures	 can	 lose	 valuable	 information.	 For	178	 example,	once	aligned	to	common	coordinate	systems,	images	can	be	analysed	for	cross-subject	variation	at	the	179	 voxel	level	to	provide	a	more	spatially-detailed	exploration	than	can	be	achieved	via	IDPs.	However,	this	requires	180	 greater	imaging	expertise	and	computational	resources,	as	well	as	often	leading	to	lower	statistical	power	(due	181	 to	the	greatly	increased	number	of	multiple	comparisons	and	the	higher	noise	in	voxel-wise	measures	compared	182	 with	regional	averages).	Below,	we	present	example	voxel-wise	associations	with	aging.		183	
Fig	5	presents	voxel-wise	correlations	of	age	with	several	parameters	modeled	 from	the	dMRI	data	(along	the	184	 centers	of	the	main	white	matter	tracts),	as	well	as	normalized	T2	FLAIR	intensity	in	the	white	matter.	Fractional	185	 anisotropy	(FA),	a	sensitive	but	non-specific	marker	of	white	matter	integrity,	predominantly	demonstrates	the	186	 established	reduction	of	FA	with	aging	(Fig	5a,g).	However,	some	voxels	exhibit	 the	opposite,	of	FA	increasing	187	 with	aging,	which	may	reflect	degradation	of	secondary	fibers	or	reduced	fiber	dispersion23;	notably,	none	of	the	188	 FA-based	 IDPs	 exhibit	 this	 significant	 positive	 correlation,	 demonstrating	 that	 averaging	 across	 tracts	 can	189	 sacrifice	 richness	 of	 information.	 The	 tensor	 mode24	 (Fig	 5b),	 which	 primarily	 describes	 whether	 a	 voxel	190	 contains	one	vs.	multiple	tracts,	was	even	more	sensitive	with	highly	significant	positive	correlations	in	certain	191	 association	fiber	areas	and	posterior	corpus	callosum	(arrows),	likely	the	same	effect	seen	as	FA	increases23.	We	192	 further	observed	an	increase	in	free	water	with	aging	(Fig	5d);	the	strongest	increase,	 in	the	fornix	(arrow),	 is	193	 likely	due	to	an	increase	of	the	fraction	of	CSF	within	voxels	spanning	this	thin	tract	as	it	atrophies.	Finally,	we	194	 calculated	voxel-wise	 cross-subject	 correlation	of	 age	with	T2	 images.	This	 analysis	 identified	peri-ventricular	195	 areas,	which	are	most	susceptible	to	white	matter	hyperintensities	known	to	be	associated	with	aging	(Fig	5e).	196	 A	 further	 example	 voxelwise	 analysis	 is	 shown	 in	 Supplementary	 Fig	 1,	 where	 the	 rfMRI	 data	 was	 used	 to	197	 investigate	 aging	 effects	 in	 the	 default-mode	 resting-state	 network25.	 This	 also	 provides	 a	 demonstration	 that	198	 group	 analyses	 do	 not	 degrade	with	 increasingly-large	 subject	 numbers	 (e.g.,	 due	 to	 alignment	 issues),	 using	199	 group	sizes	from	15	to	5000.	With	increasing	subject	numbers,	background	noise	is	suppressed	without	increase	200	 in	 spatial	 blurring,	 and	 localized	 estimates	 of	 age-dependence	 stabilize,	 with	 statistical	 significance	 rising	201	 indefinitely.	202	
	203	
Pairwise	associations	between	brain	IDPs	and	other	measures		204	 We	conducted	simple	univariate	association	analyses	to	illustrate	the	richness	of	relationships	between	IDPs	and	205	 other	available	variables,	as	well	as	the	statistical	power	afforded	by	~5000	subjects.	We	individually	correlated	206	 all	2501	brain	IDPs	with	1100	other	Biobank	variables,	where	the	latter	were	broadly	grouped	into	11	categories	207	 (Figs	1-4,6,	 Supplementary	Fig	2).	 Even	 after	 false	 discovery	 rate	 (FDR)	multiple	 comparison	 correction	 for	208	 these	 2.8	 million	 correlations,	 57	 out	 of	 the	 66	 combinations	 of	 brain	 modalities	 and	 non-brain-imaging	209	 categories	show	significant	associations.	Some	variable	categories	exhibited	large	numbers	of	associations	with	210	 IDPs	 (e.g.,	 height	 and	weight),	whereas	others	 (e.g.	 cognitive	measures	 and	 alcohol/tobacco	 intake)	had	more	211	 focused	associations.	212	 The	above	associations	were	estimated	after	adjusting	all	variables	for	age,	sex,	age-sex	interaction,	head	motion	213	 and	 head	 size	 (“de-confounding”).	 Some	 factors	 can	 be	 unambiguously	 considered	 a	 confound	 to	 be	 removed	214	 (e.g.,	head	motion,	which	can	corrupt	IDPs	but	also	correlates	with	disease/aging26).	For	other	factors	(e.g.,	age),	215	 the	 appropriateness	 of	 de-confounding	 depends	 on	 the	 question	 being	 asked	 and	 needs	 to	 be	 taken	 into	216	 consideration	 when	 interpreting	 associations	 (see	 Discussion).	 The	 relationship	 between	 the	 correlations	217	 estimated	 with	 vs.	 without	 de-confounding	 (Fig	 6d)	 demonstrates	 that	 in	 almost	 all	 cases	 the	 strength	 of	218	 association	 was	 reduced	 by	 de-confounding,	 in	 some	 cases	 being	 almost	 entirely	 removed	 (horizontal	 cloud	219	 around	y=0).	220	 We	 considered	 associations	 between	 cognitive	 tests	 and	 brain	 IDPs,	 including	 potential	 age	 interactions,	 in	221	 greater	detail.	Sex,	head	motion,	and	head	size	were	regressed	out	of	all	data	before	computing	correlations	(see	222	 Online	 Methods).	 Figure	 6b	 shows	 Bonferroni-significant	 (Puncorrected<1.8x10-8)	 associations	 with	 brain	 IDPs,	223	 both	 with	 and	 without	 adjusting	 for	 age.	 The	 task-fMRI	 vs.	 Fluid	 Intelligence	 associations	 are	 unchanged	 by	224	
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adjusting	 for	 age,	whereas	 all	 other	 cognition-IDP	 correlations	 are	 approximately	 doubled,	 being	 significantly	225	 stronger	(Pcorrected<0.005)	without	age	adjustment.	226	 In	the	Symbol	Digit	Substitution	test,	participants	replace	symbols	with	numbers	using	a	substitution	key.	Strong	227	 IDP	 associations	 were	 found	 with	 two	 scores:	Number	of	 symbol	digit	matches	made	correctly	 and	Number	of	228	
symbol	digit	matches	attempted	in	the	time	allowed	(because	subjects	rarely	make	mistakes,	these	two	scores	are	229	 highly	correlated,	r=0.97).	These	scores	correlated	negatively	with	measures	of	water	diffusivity	 in	 the	corona	230	 radiata	and	superior	thalamic	radiation,	and	with	FA	in	the	posterior	fornix	(consistent	with	literature27,	which	231	 as	 discussed	 above	may	 reflect	 variations	 in	 tract	 thickness28).	 Finally,	 there	was	 significant	 association	with	232	 thalamus	 volume	 (right	 thalamic	 volume	 significant,	 left	 thalamic	 volume	 close	 to	 significance	 with	 r=0.10),	233	 consistent	with	 literature29.	 These	 negative	 associations	 likely	 reflect	 lower	 cognitive	 performance	with	 aging	234	 and	pathology	(increased	diffusivity	and	atrophy).	235	 In	 the	Reaction	Time	 test,	 subjects	 confirm	whether	 two	abstract	 symbols	match	as	quickly	 as	possible.	Mean	236	
time	to	correctly	identify	matches	was	found	to	correlate	inversely	with	left	putamen	volume	(right	putamen	had	237	 similar	 correlation,	 r=-0.06,	 but	 was	 below	 significance).	 These	 negative	 associations	 are	 consistent	 with	238	 literature30	 and	 indicate	 increased	 volume	 correlating	 positively	 with	 cognitive	 speed	 (and	 negatively	 with	239	 reaction	time).	240	 The	Fluid	 Intelligence	 score	 reports	 how	many	numerical,	 logic	 and	 syntactic	 questions	 subjects	were	 able	 to	241	 answer	 in	 two	minutes.	 This	was	 negatively	 correlated	with	 strength	 of	 gray	matter	 activation	 in	 the	 simple	242	 shapes	matching	task	in	tfMRI,	with	no	age	interaction.	The	shapes	matching	task	incurs	low	cognitive	demand,	243	 and	 it	 is	 plausible	 that	 higher	 intelligence	 requires	 less	 neural	 activity	 for	 this	 task,	 a	 mechanism	 that	 has	244	 previously	been	ascribed	to	“minimization	of	cognitive	workload”31.		245	 All	 cognitive	 scores	 reported	 above	 involve	 processing	 speed	 as	 a	 significant	 factor,	 consistent	with	 previous	246	 studies27.	However,	the	observation	that	different	test	scores	do	not	all	correlate	identically	with	each	other	or	247	 with	the	same	brain	IDPs	suggests	that	there	is	not	a	single	(speed-related)	cognitive	factor	at	play.	The	increases	248	 in	association	strengths	when	not	controlling	for	age	suggest	that	age-related	cognitive	decline	is	a	major	source	249	 of	cross-subject	variability	for	these	IDP-cognition	associations28.	Plotting	all	IDP-cognitive	associations	(Fig	6c)	250	 demonstrated	that	a	large	number	of	non-age-adjusted	associations	(gray	circles)	were	stronger	than	the	results	251	 after	age	adjustment	(colored	circles);	below,	we	show	how	interpretation	of	such	results	can	be	aided	further	252	 through	 multivariate	 analyses.	 These	 age	 interactions	 provide	 an	 early	 indication	 that	 UK	 Biobank	 should	253	 provide	cognitive	biomarkers	of	clinical	significance	as	health	outcomes	accumulate.	254	
	255	
Multivariate	associations:	modes	of	population	variation	256	 We	 conducted	multivariate	 analyses	 using	 canonical	 correlation	 analysis	 (CCA32)	 combined	with	 independent	257	 component	analysis	(ICA33)	(see	Figs	7-8,	Supplementary	Figs	3-7	and	Online	Methods).	This	analysis	identifies	258	 “modes”	 of	 population	 covariation	 linking	 IDPs	 to	 non-imaging	 measures.	 Each	 mode	 consists	 of	 one	 linear	259	 combination	of	 IDPs	and	a	separate	combination	of	non-imaging	measures	that	have	a	highly	similar	variation	260	 across	subjects.	The	strength	of	involvement	of	a	variable	in	a	given	mode	is	dictated	by	the	variable	weight	(Fig	261	
7).	Multiple	population	modes	may	be	 identified,	provided	they	describe	different	(independent)	cross-subject	262	 variation,	meaning	that	the	implied	association	between	a	given	pair	of	variables	can	vary	from	mode	to	mode.		263	 From	the	current	UK	Biobank	release,	we	identified	nine	modes	that	were	highly	significant	(Pcorrected<0.002,	no	264	 further	modes	significant	at	Pcorrected<0.05).	Similar	methodology	using	Human	Connectome	Project	 (HCP)	data	265	 previously	 identified	 a	 single	 statistically-significant	 mode	 of	 population	 covariation	 in	 461	 young	 healthy	266	 adults8,	34.	Our	ability	to	identify	more	modes	than	in	the	HCP	dataset	could	be	due	to	the	tenfold	increase	in	the	267	 number	of	subjects,	the	larger	range	of	imaging	modalities	and	non-imaging	variables,	and	the	older	subject	ages.		268	 While	 these	 modes	 are	 not	 guaranteed	 to	 reflect	 biological	 processes,	 in	 practice	 ICA	 often	 produces	 such	269	 interpretability35.	 Of	 the	 nine	modes,	 some	 reflected	 dominant	 physical	 factors	 (e.g.,	 body	 size	 or	 heart	 rate),	270	 while	others	linked	rich	subsets	of	non-imaging	measures	to	IDPs.	Modes	7-9	are	displayed	in	Fig	7,	with	modes	271	 7	 and	9	discussed	 in	detail	 below,	 continuing	our	 focus	on	 the	 relationship	between	 IDPs	 and	 cognitive	 tests.	272	 Modes	1-6	 are	overviewed	 in	Supplementary	Figs	3-7.	The	 relationship	of	 these	multivariate	 associations	 to	273	 potential	confounds	and	variables	of	 interest,	 including	some	clinical	outcomes,	 is	explored	in	Supplementary	274	
Fig	8.	Modes	1,2,4,5,7,8	were	strongly	associated	with	aging,	whereas	3,6,9	were	not.		275	 Mode	7	primarily	links	bone	density	measures	and	cognitive	scores	to	brain	structure	and	dMRI	measures.	There	276	 is	 extensive	 literature	 linking	 volume	 and	 diffusivity	measures	 to	 cognition,	 but	 a	 relationship	 between	 these	277	 measures	and	bone	density	has	not	to	our	knowledge	been	reported.	This	link	could	reflect	variations	in	physical	278	 properties	 of	 non-interest	 that	 are	 not	 fully	 accounted	 for	 by	de-confounding.	However,	 correlations	 between	279	
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low	bone	density	and	accelerated	cognitive	decline	have	been	reported36	 including	association	of	bone	density	280	 with	Alzheimer’s	disease37.	281	 Mode	 9	 exhibited	 the	 most	 complex	 population	 pattern	 (Fig	 7c).	 The	 most	 strongly-involved	 non-imaging	282	 measures	were	 intelligence,	 education	 levels	and	occupational	 factors;	 additionally,	 some	physical	 and	dietary	283	 measures	are	involved,	that	may	reflect	socio-economic	status	as	a	latent	factor	(e.g.,	cheese	intake	or	time	spent	284	
outdoors	in	winter).	Associated	brain	IDPs	include	task	fMRI	(with	a	negative	weight,	consistent	with	the	sign	of	285	 univariate	associations,	discussed	above),	followed	by	a	range	of	functional	and	structural	IDPs.		286	 There	 is	 some	 overlap	 between	modes	 7	 and	 9	 in	 terms	 of	 cognitive	 tasks	 (e.g.,	 symbol	digit	matches),	 bone	287	 density	and	T1-based	brain	volumes.	However,	the	fact	that	CCA-ICA	separated	modes	7	and	9	indicates	that	they	288	 constitute	 distinct	 biophysical	 patterns	 of	 variation	 across	 subjects;	 for	 example,	mode	 7	 correlates	with	 age,	289	 while	 mode	 9	 does	 not.	 The	 broader	 range	 of	 non-imaging	 measures	 involved	 in	 mode	 9,	 and	 the	 ability	 to	290	 interpret	many	of	them	in	terms	of	positive	or	negative	life	factors,	is	reminiscent	of	the	single	mode	previously	291	 reported	 from	 HCP	 data8,	34.	 That	 mode	 resembled	 the	 well-established	 observation	 of	 strong	 correlations	 in	292	 subject	performance	across	a	broad	range	of	cognitive	and	behavioral	tests	(the	“general	intelligence”	g-factor),	293	 but	also	included	demographic	and	life	factors.	However,	there	is	not	perfect	correspondence	between	mode	9	294	 reported	here	and	the	previous	HCP	mode.	This	may	be	due	to	key	differences	in	the	HCP	and	Biobank	datasets,	295	 including	different	non-imaging	measures,	the	use	of	only	rfMRI	in	the	HCP	analysis,	the	different	cohort	profiles	296	 (e.g.,	age	range)	and	the	ability	to	separate	more	modes	from	the	larger	Biobank	cohort.	297	 	298	
Illustrative	hypothesis-driven	study	299	 The	Austrian	Stroke	Prevention	Study	(ASPS)	recently	reported	associations	between	aging,	smoking	and	body	300	 mass	index	(BMI)	with	gray	matter	T2*	in	314	participants	(38-82	years)38,	likely	reflecting	iron	accumulation	in	301	 local	 tissue13.	 We	 sought	 to	 replicate	 several	 of	 their	 key	 findings	 as	 a	 demonstration	 of	 a	 hypothesis-led	302	 investigation.	The	ASPS	study	reported	R2*,	which	is	the	reciprocal	of	the	T2*	value	we	estimate	in	UK	Biobank;	303	 therefore	we	 expected	T2*	 associations	with	 opposite	 sign	 to	 those	 reported	 by	ASPS.	 The	main	 results	 from	304	 ASPS	in	deep	gray	matter	structures	were	as	follows:	BMI	was	the	strongest	determinant	of	R2*	generally,	and	305	 was	significantly	related	to	R2*	in	amygdala	(beta=0.23,	PFDR=0.009)	and	hippocampus	(beta=0.14,	PFDR<0.0001).	306	 Further	 associations	 with	 R2*	 (averaged	 across	 subcortical	 structures)	 were	 found	 for	 age	 (beta=0.03,	 PFDR	307	 =0.027)	 and	 recent	 smoking	 level	 (beta=0.02,	 PFDR=0.001).	 No	 equivalent	 associations	 were	 found	 for	 sex	 or	308	 hypertension.	The	ASPS	conducted	univariate	correlations	and	multiple	regressions	to	identify	both	shared	and	309	 unique	 variance	 in	 the	 associations,	 using	 FDR	 correction.	 Based	 on	 these	 results,	 we	 hypothesize	 negative	310	 association	between	T2*	in	subcortical	structures	with	BMI,	age	and	smoking.		311	 We	conducted	similar	analyses,	applying	univariate	correlations	and	multiple	regressions	against	a	similar	set	of	312	 covariates	 to	ASPS	 (see	Fig	8).	 The	 regressions	used	 the	n=4,891	 subjects	with	 complete	data	 in	 all	 IDPs	 and	313	 covariates.	 In	 order	 to	 maximize	 the	 complementarity	 of	 information	 content	 between	 the	 univariate	314	 correlations	 and	 multiple	 regressions,	 no	 adjustments	 for	 factors	 such	 as	 age	 and	 sex	 were	 applied	 in	315	 correlations,	whereas	 these	 factors	were	 included	 as	 confound	 covariates	 in	 the	multivariate	 regressions.	We	316	 applied	 Bonferroni	 multiple	 comparisons	 correction	 across	 covariates	 and	 brain	 regions,	 resulting	 (for	317	 Pcorrected<0.05)	in	a	-log10Puncorrected		threshold	of	3.6.	318	 Our	results	were	highly	concordant	with	ASPS.	BMI	was	significantly	associated	with	T2*	in	amygdala	(averaged	319	 across	 left	 and	 right:	 beta=-0.07,	 -log10Puncorrected=3.9)	 and	 hippocampus	 (beta=-0.15,	 -log10Puncorrected=17.0;	 for	320	 comparison,	FDR	correction	would	result	in	PFDR<10-10).	Individual	subcortical	BMI	associations	are	shown	in	Fig	321	
8b.	In	accordance	with	our	hypothesis,	the	signs	of	regression	betas	are	universally	negative	with	T2*	from	UK	322	 Biobank	data.	Associations	with	T2*	were	found	for	age	in	thalamus,	caudate	and	putamen	(see	Fig	8c)	and	for	323	 smoking	status	in	caudate,	putamen	and	right	pallidum	(beta	ranging	from	-0.03	to	-0.1).	Association	of	T2*	with	324	 sex	was	only	found	in	right	amygdala,	and	no	association	was	found	for	hypertension.	325	 The	 increased	 specificity	 of	 multiple	 regression	 is	 notable	 for	 many	 of	 the	 tests	 –	 for	 example,	 a	 significant	326	 univariate	association	of	T2*	with	cholesterol	disappears	after	controlling	for	the	other	covariates.	Similarly,	for	327	 T2*	in	hippocampus	and	amygdala,	many	of	the	associations	with	age,	sex,	BMI	and	other	factors	become	much	328	 weaker	after	controlling	for	all	variables,	in	particular	amount	of	head	motion.	Despite	the	fact	that	this	motion	329	 was	recorded	from	the	functional	data	(not	the	T2*	data),	it	is	likely	a	general	indicator	of	head	motion,	and	these	330	 results	illustrate	why	interpretation	of	imaging	associations	requires	care.	For	example,	BMI	could	be	predictive	331	 of	head	motion	(e.g.,	comfort	in	the	scanner)	while	also	potentially	relating	to	biophysical	parameters	of	deeper	332	 interest.	333	 The	 BMI	 and	 smoking	 associations	 with	 T2*	 are	 found	 in	 distinct	 subcortical	 structures.	 Interestingly,	 this	334	 distinction	 is	 reflected	 in	 the	CCA-ICA	 results,	where	 these	associations	appear	 in	 separate	population	modes.	335	
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The	association	of	T2*	in	caudate	and	putamen	with	smoking	(and	more	weakly	with	alcohol,	Fig	8c)	 is	highly	336	 concordant	 with	 CCA-ICA	 mode	 5	 (Supplementary	 Fig	 4b),	 and	 is	 associated	 with	 aging	 (Fig	 8c	 and	337	
Supplementary	Fig	8).	The	association	of	T2*	in	hippocampus	and	amygdala	with	BMI	is	highly	concordant	with	338	 CCA-ICA	mode	3	(Supplementary	Fig	3c),	a	distinct	mode	of	population	covariation	that	is	not	associated	with	339	 aging	(in	either	analysis).	Neither	mode	includes	cognitive	test	scores,	suggesting	that	while	these	associations	340	 clearly	relate	to	biological	processes,	they	may	be	only	indirectly	linked	to	cognitive	health.	341	
	342	
DISCUSSION	343	
Challenges	of	population	imaging	344	 UK	 Biobank	 data	 is	 openly	 available	 to	 researchers	 including	 non-imaging	 experts.	 However,	 imaging	 data	 is	345	 considerably	 more	 complex	 than	 most	 of	 the	 existing	 UK	 Biobank	 measures.	 Extensive	 post-processing	 is	346	 required	to	align	images	across	subjects	and	remove	artefacts.	Moreover,	information	is	usually	encoded	across	347	 multiple	 voxels,	 requiring	 further	 processing	 to	 extract	 relevant	 features.	 Even	with	 carefully-prepared	 IDPs,	348	 meaningful	interpretation	requires	care	because	MRI	is	generally	an	indirect	measure	of	the	biology	of	interest.	349	 Apparent	structural	atrophy	can	be	susceptible	to	misinterpretation39;	functional	MRI	signals	can	reflect	vascular	350	 properties	rather	than	neural	activity40;	and	diffusion	MRI	is	sensitive	to	many	aspects	of	tissue	microstructure14.	351	 A	 final	 challenge	 is	 that	 data	 sizes	 have	 become	 extremely	 large,	 requiring	 “big	 data”	 techniques;	 the	 brain	352	 imaging	data	in	UK	Biobank	will	ultimately	surpass	0.2PB	even	without	data	inflation	during	post-processing.	353	 Large	cohorts	face	the	further	challenge	that	statistically	significant	associations	are	identified	even	when	their	354	 explanatory	power	is	small.	In	the	present	dataset,	significance	is	reached	at	a	correlation	of	just	r≈0.1,	i.e.,	1%	of	355	 population	 variance	 explained41	 even	 with	 multiple	 comparison	 correction.	 Large	 genome-wide	 association	356	 studies	 (GWAS)	 face	 this	 challenge,	where	 it	 is	accepted	 that	 small	 effect	 sizes	can	be	meaningful,	particularly	357	 where	multiple	factors	combine	to	create	a	large	effect.	However,	in	GWAS,	genetic	variants	can	be	interpreted	as	358	 causal	 factors	 (whether	 direct	 or	 indirect42),	 whereas	 apparent	 associations	 across	 IDPs	 and	 non-imaging	359	 phenotypes	could	result	from	a	shared	latent	(non-measured)	cause.	For	example,	education	level	could	result	in	360	 a	 dietary	 factor	 associating	with	 a	 brain	 IDP,	 despite	 no	 direct	 causal	 connection	 between	 diet	 and	 IDP.	 This	361	 danger	 is	 inflated	with	 larger	subject	numbers,	but	may	here	be	mitigated	by	the	rich	 life	 factor	and	biological	362	 variables	that	can	be	controlled	for	or	used	to	match	sub-groups.	Population	variances	explained	in	the	pairwise	363	 associations	reached	maxima	of	around	5%	(Supplementary	Fig	2),	but	these	are	higher	with	the	multivariate	364	 analyses	 (up	 to	 20-50%	 variance	 explained	 in	 the	most	 highly	 involved	 variables	 within	 population	modes),	365	 partly	reflecting	increased	sensitivity	gained	when	appropriately	combining	across	related	variables.	366	 The	 importance	of	accounting	 for	relevant	confounds	 is	exemplified	 in	Fig	6e,	which	shows	a	strong	apparent	367	 association	between	total	white	matter	volume	and	 fat-free	body	mass	(one	scatter	point	per	subject)	without	368	 de-confounding.	In	fact,	this	association	is	largely	driven	by	the	average	differences	in	body	mass	and	head	size	369	 between	sexes	(see	color	coding)	and	disappears	after	adjusting	for	sex,	age	and	head	size.	This	is	an	example	of	370	 Simpson’s	paradox43,	in	which	suboptimal	pooling	across	variables	(here,	sex)	results	in	a	misleading	association.	371	 Other	pitfalls	 include	failing	to	consider	study	population	selection	bias44	and	inappropriate	de-confounding	of	372	 variables	that	are	caused	by	(and	not	feeding	into)	the	variables	of	interest45.	While	there	is	no	guarantee	that	UK	373	 Biobank	is	an	unbiased	sample	of	the	full	population,	that	does	not	imply	that	studies	using	subsets	of	the	data	374	 have	 to	 retain	 any	 biases	 (though	 again	 it	 is	 still	 possible	 for	 bias	 to	 arise44);	 one	 important	 aspect	 of	 study	375	 design	will	be	 the	method	of	 sub-selection	of	Biobank	subjects	 to	 feed	 into	an	analysis.	 In	 the	 case	of	 focused	376	 hypothesis	testing,	it	is	likely	that	carefully	selected	sub-groups	of	subjects	should	be	utilized.	For	example,	once	377	 a	group	of	subjects	is	identified	with	a	clinical	diagnosis,	it	is	likely	that	optimal	sensitivity	and	interpretability	378	 will	require	a	control	sub-group	that	is	matched	over	many	relevant	factors	(e.g.	sex,	age,	relevant	life	factors	not	379	 appearing	in	the	predictive	model).	380	 Future	studies	might	seek	to	find	causalities	between	variables,	for	example	using	structural	equation	modeling,	381	 Bayes	 Nets	 or	 non-linear/non-Gaussian	 methods46.	 The	 dangers	 of	 inferring	 causalities	 from	 observational	382	 datasets	 like	UK	Biobank	are	well-known;	the	inclusion	of	genotype	and	other	“instrumental”	measures	enable	383	 analyses	such	as	Mendelian	randomization,	although	important	caveats	must	be	considered42.	The	safest	way	to	384	 confirm	causal	results	discovered	from	such	observational	datasets	is	to	use	such	results	to	form	hypotheses	for	385	 new	focused	interventional	studies.	386	 The	 mapping	 of	 disease	 associations	 and	 population	 patterns	 (e.g.,	 learned	 from	 UK	 Biobank	 data)	 onto	387	 individuals	will	be	an	important	long-term	goal.	For	example,	population	distributions	of	imaging	measures	and	388	 health	outcomes	can	be	learned,	and	used	to	form	patient-specific	prior	distributions	to	combine	with	measures	389	 from	 a	 new	 patient.	 While	 this	 might	 not	 provide	 statistical	 certainty	 for	 a	 diagnosis	 or	 interventional	390	 recommendation,	it	should	allow	for	single-patient	imaging	to	be	used	in	a	similar	way	to	current	state-of-the-art	391	 patient-tuned	genetic	testing.	392	
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	393	
Data	analysis	in	population	imaging	394	 The	analyses	presented	here	demonstrate	some	of	the	possibilities	offered	by	the	UK	Biobank	resource.	Focused	395	 association	studies	may	select	just	two	variables	to	investigate,	for	example,	one	IDP	correlated	against	one	life	396	 factor,	genetic	marker,	physical	assay	or	health	outcome.	More	complex	analyses	could	model	a	larger	number	of	397	 variables	simultaneously,	for	example,	looking	to	predict	health	outcome	from	multiple	linear	regression	against	398	 several	 predictor	 variables.	 Nonlinear	 methods	 (e.g.	 penalized	 regression	 or	 data-driven	 feature	 selection)22	399	 could	 enable	 use	 of	 much	 larger	 number	 of	 predictor	 variables.	 A	 further	 extension	 could	 identify	 nonlinear	400	 interactions	 between	 predictor	 variables,	 for	 example	 considering	 an	 imaging	 measure,	 a	 life	 factor	 and	 an	401	 interaction	 term	 between	 the	 two	 as	 three	 distinct	 predictors.	 An	 even	more	 complex	 analysis	might	 predict	402	 multiple	 outcome	 variables,	 looking	 for	 “doubly-multivariate”	 associations	 between	 two	 or	 more	 sets	 of	403	 variables;	the	CCA-ICA	analyses	presented	above	are	an	example	of	this.	Finally,	imaging	measures	may	in	some	404	 cases	be	more	sensitive	or	specific	than	clinical	symptoms47,	thereby	providing	proxies	for	healthcare	outcomes	405	 and/or	enabling	clustering	of	patients	that	is	more	predictive	of	prognosis	or	therapeutic	response48.	406	 Pairwise	correlation	analyses	result	in	simple	outcomes	that	require	an	understanding	of	the	caveats	in	imaging-407	 derived	 measures.	 Data-driven	 multivariate	 analyses	 identifying	 associations	 between	 sets	 of	 variables	 have	408	 complementary	benefits,	including	improved	sensitivity	to	biological	processes	and	a	streamlined	set	of	results	409	 compared	with	millions	of	univariate	associations.	Further,	multivariate	analyses	can	separate	distinct	biological	410	 processes	with	opposing	relationships	between	variables.	For	example,	our	CCA-ICA	analysis	revealed	one	aging-411	 related	process	 that	 involved	 changes	 in	 heart	 rate	 and	 fMRI	measures	 (mode	4)	while	 another	 aging-related	412	 process	related	blood	pressure	and	white	matter	microstructure	(mode	8).	A	simple	correlational	analysis	would	413	 show	associations	between	all	of	these	factors,	including	even	those	that	appeared	in	separate	modes	(e.g.	fMRI	414	 and	 white	 matter	 changes).	 Additionally,	 as	 with	 multiple	 regression,	 simultaneous	 identification	 of	 multiple	415	 modes	of	association	reduces	the	unexplained	residual	variance	(effectively	data	“de-noising”).	416	 Multivariate	 analyses	 of	 multi-modal	 data	 like	 UK	 Biobank	 enable	 discovery	 of	 (potentially	 complex)	 clinical	417	 phenotypes.	This	is	a	powerful	alternative	to	diagnostic	categories	that	rely	on	clinical	symptoms	which	do	not	418	 map	 cleanly	 onto	 underlying	 disease	 mechanisms.	 For	 many	 complex	 diseases,	 the	 discovery	 of	 distinct	419	 mechanisms/sub-diseases	that	are	currently	conflated	may	be	unlikely	to	occur	solely	through	symptom-based	420	 investigations.	 Discovering	 relevant	 population	 axes	 and	 sub-groups	 based	 on	 imaging,	 genetics	 and	 other	421	 objective	markers	may	therefore	be	expected	to	increase	our	understanding	of	the	etiology	and	pathogenesis	of	a	422	 wide	 variety	 of	 diseases.	 For	 example,	 this	 concept	 is	 at	 the	 heart	 of	 the	 recently-proposed	Research	Domain	423	 Criteria	(RDoC)	in	psychiatry48.	424	
	425	
Population	imaging	landscape	426	 In	 the	 early	 2000s,	 several	 ambitious	 studies	 built	 cohorts	 numbering	 thousands	 of	 subjects.	 	 Several	 recent	427	 brain	 imaging	 studies	 are	 aiming	 to	 image	 tens	 of	 thousands	 of	 subjects,	 including	 the	 Maastricht	 Study	428	 (n=10,000)49,	 the	 German	 National	 Cohort	 (n=30,000)50	 and	 the	 Rhineland	 Study	 (n=30,000).	 In	 addition	 to	429	 having	 even	 larger	 numbers,	 UK	 Biobank	 will	 benefit	 from	 the	 breadth	 of	 organ	 systems	 imaged,	 the	 highly	430	 multi-modal	brain	protocol,	and	the	existing	rich	phenotyping.	A	longitudinal	component	is	planned	for	a	subset	431	 of	the	UK	Biobank	imaging	participants	(n=10,000),	as	in	the	Rhineland	and	GNC	studies.	Most	of	these	studies	432	 use	identical	MRI	scanners	at	a	small	number	of	dedicated	sites,	with	the	goal	of	maximizing	data	homogeneity	433	 within	study.	A	 future	challenge	to	 further	 leveraging	these	 large	datasets	 is	 to	develop	analysis	 tools	 that	can	434	 harmonize	 data	 across	 these	 studies	 for	 combined	 analyses,	 where	 there	 could	 be	 considerable	 impact	 in	435	 focusing	on	harmonization	of	a	few	very	large	cohorts.	436	 Even	with	just	5%	of	the	eventual	cohort	size,	the	results	presented	here	demonstrate	the	statistical	benefits	that	437	 are	conferred	by	large	numbers.	However,	the	primary	rationale	for	the	size	of	the	study	is	not	to	boost	statistical	438	 power	 across	 100,000	 subjects,	 but	 rather	 to	 provide	 prospective	 imaging	 data	 suitable	 for	 discovering	 early	439	 markers	and	risk	factors	for	as	broad	a	set	of	diseases	as	possible.	For	some	rare	diseases	with	few	established	440	 risk	 factors,	 this	 approach	 is	 uniquely	 suited	 to	 discovery	 of	 pre-symptomatic	 markers;	 for	 example,	 50-100	441	 imaging	 participants	 are	 expected	 to	 develop	 sporadic	 amyotrophic	 lateral	 sclerosis	 (ALS)	 by	 2027.	 This	 rich	442	 imaging	addition	to	the	ongoing	UK	Biobank	study	will	provide	scientists	with	novel	insights	into	the	causes	of	443	 brain	disease,	provide	markers	with	predictive	power	 for	 therapeutic	 interventions,	and	advance	non-invasive	444	 imaging-based	screening	for	preventative	healthcare.	445	
	446	
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Figure	captions	566	
Figure	 1	 	 Data	 from	 the	 three	 structural	 imaging	 modalities	 in	 UK	 Biobank	 brain	 imaging.	 (a)	 Single-subject	 T1-567	 weighted	structural	image	with	minimal	pre-processing:	removal	of	intensity	inhomogeneity,	lower	neck	areas	cropped	and	568	 the	 face	blanked	 to	protect	 anonymity.	Color	overlays	 show	automated	modeling	of	 several	 subcortical	 structures	 (above)	569	 and	segmentation	of	gray	matter	(below).	(b)	Single-subject	T2-weighted	FLAIR	image	with	the	same	minimal	pre-processing,	570	 showing	hyperintense	lesions	in	the	white	matter	indicated	(arrows).	(c)	Group-average	(n≈4500)	T1	atlas;	all	subjects’	data	571	 were	 aligned	 together	 (see	Online	Methods	 for	processing	details)	 and	 averaged,	 achieving	higher	quality	 alignment,	with	572	 clear	delineation	of	deep	grey	structures	and	good	agreement	of	major	sulcal	folding	patterns	despite	wide	variation	in	these	573	 features	across	subjects.	(d)	Group-average	T2	FLAIR	atlas.	(e)	Group-average	atlas	derived	from	SWI	processing	of	swMRI	574	 phase	and	magnitude	images.	(f)	Group-average	T2*	atlas,	also	derived	from	the	swMRI	data.	(g)	“Manhattan”	plot	(a	layout	575	 common	in	genetic	studies)	relating	all	25	IDPs	from	the	T1	data	to	1100	non-brain-imaging	variables	extracted	from	the	UK	576	 Biobank	 database,	 with	 the	 latter	 arranged	 into	major	 variable	 groups	 along	 the	 x	 axis	 (with	 these	 groups	 separated	 by	577	 vertical	dotted	lines).	For	each	of	these	1100	variables,	the	significance	of	the	cross-subject	univariate	correlation	with	each	578	 of	the	IDPs	is	plotted	vertically,	in	units	of	–log10(Puncorrected).	The	dotted	horizontal	lines	indicate	thresholds	corresponding	to	579	 multiple	 comparison	 correction	 using	 false	 discovery	 rate	 (FDR,	 lower	 line,	 corresponding	 to	 puncorrected=3.8×10-5)	 and	580	 Bonferroni	 correction	 (upper	 line,	 puncorrected=1.8×10-8)	 across	 the	 2.8	million	 tests	 involving	 correlations	 of	 all	modalities’	581	 IDPs	 against	 all	 1100	 non-imaging	measures.	 Effects	 such	 as	 age,	 sex	 and	 head	 size	 are	 regressed	 out	 of	 all	 data	 before	582	 computing	the	correlations.	As	an	indication	of	the	corresponding	range	of	effect	sizes,	the	maximum	r2	(fractional	variance	of	583	 either	 variable	 explained	 by	 the	 other)	 is	 calculated,	 as	 well	 as	 the	 minimum	 r2	 across	 all	 tests	 passing	 the	 Bonferroni	584	 correction.	 Here	 the	 maximum	 r2	 =	 0.045	 and	 the	 minimum	 r2	 =	 0.0058.	 See	 Online	 Methods	 for	 more	 details	 of	 these	585	 analyses.	(h)	Plot	relating	all	14	T2*	IDPs	to	1100	non-imaging	variables.	Maximum	r2	=	0.034,	minimum	r2	=	0.0063.	Marked	586	 Bonferroni	and	FDR	multiple	comparison	threshold	levels	are	the	same	as	in	(g).	587	
Figure	2	 	 	The	diffusion	MRI	data	 in	UK	Biobank.	 (a)	Group-average	 (n≈4500)	 atlases	 from	six	distinct	dMRI	modeling	588	 outputs,	each	sensitive	to	different	aspects	of	the	white	matter	microarchitecture.	See	Online	Methods	for	processing	details.	589	 The	atlases	shown	are:	FA	(fractional	anisotropy),	MD	(mean	diffusivity)	and	MO	(tensor	mode);	ICVF	(intra-cellular	volume	590	 fraction),	 ISOVF	 (isotropic	 or	 free	 water	 volume	 fraction)	 and	 OD	 (orientation	 dispersion	 index),	 from	 the	 NODDI	591	 microstructural	modeling.	Also	shown	are	several	group-average	white	matter	masks	used	to	generate	IDPs	(e.g.,	pink	(r)	are	592	 retrolenticular	tracts	 in	the	internal	capsules;	upper-green	(s)	are	the	superior	 longitudinal	 fasciculi).	(b)	Tensor	ellipsoids	593	 depicting	the	group-averaged	tensor	fit	at	each	voxel	for	the	region	shown	inset	in	(c).	The	shapes	of	the	ellipsoids	indicate	594	 the	 strength	 of	water	 diffusion	 along	 three	 principal	 directions;	 long	 thin	 tensors	 indicate	 single	 dominant	 fiber	 bundles,	595	 whereas	 more	 spherical	 tensors	 (within	 white	 matter)	 generally	 imply	 regions	 of	 crossing	 fibers	 (seen	 more	 explicitly	596	 modeled	in	corresponding	parts	of	(c)).	(c)	Group-averaged	multiple	fiber	orientation	atlases,	showing	up	to	3	fiber	bundles	597	 per	 voxel.	 Red	 shows	 the	 strongest	 fiber	 direction,	 green	 the	 second,	 and	blue	 the	 third.	 Each	 fiber	 bundle	 is	 only	 shown	598	 where	the	modeling	estimates	that	population	to	have	greater	than	5%	voxel	occupancy.	Inset	shows	the	thresholded	mean	599	 FA	 image	 (copper)	overlaid	on	 the	T1,	with	 the	 region	 shown	 in	detail	 in	 (b)	and	c)	highlighted.	 (d)	Four	example	group-600	 average	white	matter	tract	atlases	estimated	by	probabilistic	tractography	fed	from	the	within-voxel	fiber	modeling:	corpus	601	 callosum	(genu),	superior	longitudinal	fasciculus,	corticospinal	tract	and	inferior	fronto-occipital	fasciculus.	(e)	Plot	relating	602	 all	 675	 dMRI	 IDPs	 (nine	 distinct	 dMRI	modeling	 outputs	 from	 tensor	 and	NODDI	models	 ×	 75	 tract	masks)	 to	 1100	non-603	 imaging	variables	(see	Fig	1g	for	details).		Maximum	r2	=	0.057,	minimum	r2	(passing	Bonferroni)	=	0.0065.	Dotted	horizontal	604	 lines	(multiple	comparison	thresholds)	are	the	same	as	in	Fig	1g.	605	
Figure	3			The	task	fMRI	data	in	UK	Biobank.	(a)	The	task	paradigm	temporal	model	(time	running	vertically)	depicting	the	606	 periods	 of	 the	 two	 task	 types	 (shapes	 and	 faces);	 for	 more	 information	 on	 this	 paradigm	 view,	 see	607	 http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FEAT/UserGuide.	 (b)	 Example	 fitted	 activation	 regression	 model	 vs.	 timeseries	 data	608	 (time	 running	 horizontally),	 for	 the	 voxel	 most	 strongly	 responding	 to	 the	 “faces	 >	 shapes”	 contrast	 in	 a	 single	 subject	609	 (Z=12.3).	(c)	Percentage	of	subjects	passing	simple	voxel-wise	activation	thresholding	(Z>1.96)	for	the	same	contrast.	Note	610	 reliable	focal	activation	in	left	and	right	amygdala.	The	underlying	image	is	the	group-averaged	raw	fMRI	image.	(d)	Group-611	 averaged	activation	for	the	3	contrasts	of	most	interest,	overlaid	on	the	group-average	T1	atlas	(fixed-effects	group	average,	612	 Z>100,	voxelwise	Pcorrected<10-30).	(e)	Plot	relating	the	16	tfMRI	IDPs	to	1100	non-imaging	variables	(see	Fig	1g	for	details).	613	 Maximum	r2	=	0.018,	minimum	r2	(passing	Bonferroni)	=	0.0062.	Dotted	horizontal	 lines	(multiple	comparison	thresholds)	614	 are	the	same	as	in	Fig	1g.	615	
Figure	4	 	 	The	 resting-state	 fMRI	data	 in	UK	Biobank.	 (a)	 Example	 group-average	 resting-state	 network	 (RSN)	 atlases	616	 from	 the	 low-dimensional	 group-average	 decomposition,	 showing	 four	 out	 of	 21	 estimated	 functional	 brain	 networks,	617	 including	the	default	mode	network	(red-yellow),	dorsal	attention	network	(green),	primary	visual	(copper),	and	higher	level	618	 visual	(dorsal	and	ventral	streams,	blue).	The	three	slices	shown	are	(top	to	bottom)	sagittal,	coronal	and	axial.	(b)	The	55	619	 non-artefact	components	from	a	higher-dimensional	parcelation	of	the	brain	(axial	views).	These	are	shown	as	displayed	by	620	 the	connectome	browser	(www.fmrib.ox.ac.uk/analysis/techrep/ukb/netjs_d100),	which	allows	 interactive	 investigation	of	621	 individual	 connections	 in	 the	 group-averaged	 functional	 network	 modeling.	 The	 55	 brain	 regions	 (network	 nodes)	 are	622	 clustered	into	groups	according	to	their	average	population	connectivity,	and	the	strongest	individual	connections	are	shown	623	 (positive	in	red,	anticorrelations	in	blue).	(c)	Plot	relating	the	76	rfMRI	“node	amplitude”	IDPs	to	1100	non-imaging	variables	624	 (see	Fig	1g	 for	details).	Maximum	r2	=	0.065,	minimum	r2	 (passing	Bonferroni)	=	0.0059.	 (d)	Plot	 relating	 the	1695	rfMRI	625	 “functional	connectivity”	IDPs	to	1100	non-imaging	variables.	Maximum	r2	=	0.032,	minimum	r2	=	0.0059.	Dotted	horizontal	626	 lines	(multiple	comparison	thresholds)	in	(c)	and	(d)	are	the	same	as	in	Fig	1g.	627	
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Figure	5			Voxel-wise	correlations	of	participants’	age	against	several	white	matter	measures	from	the	dMRI	and	T2	628	
FLAIR	data.	(a)	Voxel-wise	(cross-subject)	correlation	of	FA	(fractional	anisotropy)	vs.	age.	Group-average	FA	in	white	629	 matter	is	shown	in	green,	overlaid	onto	the	group-average	T1.	(b)	Correlation	of	MO	(tensor	mode)	vs.	age,	using	the	same	630	 color	scheme.	Nearby	areas	of	MO	increase	are	shown	in	greater	detail	in	(f),	which	also	shows	the	distinct	primary	fiber	631	 directions.	(c)	Correlation	of	OD	(orientation	dispersion)	vs.	age,	including	a	reduction	in	dispersion	in	posterior	corpus	632	 callosum.	(d)	Correlation	of	ISOVF	(isotropic	or	free	water	volume	fraction)	vs.	age,	showing	increases	in	“free	water”	with	633	 age	in	a	broad	range	of	tracts.	(e)	Voxel-wise	correlation	of	T2	FLAIR	intensity,	showing	increased	intensity	with	aging	in	634	 white	matter.	For	(a-e),	blue	and	red-yellow	show	negative	and	positive	Pearson	correlation	with	age,	respectively	635	 (Pcorrected<0.05,	with	Bonferroni	correction	across	voxels	resulting	in	significance	at	r=0.1	(dMRI	n=3722;	T2	FLAIR	n=3781).	636	 (g)	Histograms	(across	voxels)	of	the	voxel-wise	age	correlation	of	the	correlation	maps	shown	above,	with	correlation	value	637	 on	the	x	axis.	FA	and	MO	largely	decrease	with	age,	while	OD	and	ISOVF	largely	increase.	638	
Figure	6		 	Visualisation	of	2.8	million	univariate	cross-subject	association	tests	between	2501	IDPs	and	1100	other	639	
variables	in	the	UK	Biobank	database.	(a)	Manhattan	plot	showing,	for	each	of	the	1100	non-brain-imaging	variables,	the	640	 statistically	strongest	association	of	 that	variable	with	each	distinct	 imaging	sub-modality’s	 IDPs.	 (i.e.,	6	 results	plotted	 for	641	 each	x	axis	position,	each	with	a	color	indicating	a	brain	imaging	modality;	this	plot	differs	from	the	other	Manhattan	plots,	642	 which	 show	 correlations	 with	 all	 IDPs).	 Whereas	 the	 Manhattan	 plots	 in	 Figs	 1-4	 indicated	 associations	 for	 each	 brain	643	 imaging	modality	separately,	here	we	depict	all	associations	 in	a	single	plot.	 (b)	List	of	all	 IDP-cognitive	score	associations	644	 passing	Bonferroni	 correction	 for	multiple	 comparisons	 (Pcorrected<0.05;	Puncorrected<1.8x10-8).	The	 first	 column	 lists	 the	age-645	 adjusted	correlation	coefficient,	and	the	second	shows	the	unadjusted	correlation,	both	being	correlations	between	a	specific	646	 brain	 IDP	 (fifth	 column)	and	a	 cognitive	 test	 score	 (seventh	column).	UK	Biobank	cognitive	 tests	 carried	out	 include	Fluid	647	 Intelligence,	Prospective	Memory,	Reaction	Time	(Shape	Pairs	Matching),	Memorised	Pairs	Matching,	Trail	Making	(Symbol	648	 Ordering),	Symbol	Digit	Substitution,	and	Numeric	Memory.	(c)	IDP	associations	with	the	cognitive	phenotype	variables	(the	649	 full	 set	 of	 174	 cognitive	 variables,	 repeated	 for	 each	 brain	 imaging	 modality).	 Shown	 behind,	 in	 gray,	 are	 the	 same	650	 associations	 without	 adjustment	 for	 age,	 with	 a	 large	 number	 of	 stronger	 associations.	 Dotted	 horizontal	 lines	 (multiple	651	 comparison	thresholds)	in	(a)	and	(c)	are	the	same	as	in	Fig	1g.	(d)	Scatterplot	showing	the	relationship	between	adjusted	652	 correlations	and	those	obtained	without	first	regressing	out	the	confound	variables	(each	point	is	a	pairing	of	one	IDP	with	653	 one	 non-brain-imaging	 variable,	 2.8	 million	 points).	 The	 grid	 lines	 indicate	 Bonferroni-corrected	 significance	 level	 (as	654	 described	in	Fig	1).	(e)	Example	association	between	unadjusted	white	matter	volume	and	fat-free	body	mass	is	high	(r=0.56)	655	 when	pooling	across	the	sexes.	After	adjusting	for	several	variables	(including	sex),	the	correlation	falls	almost	to	zero.	656	
Figure	 7	 	 	 Details	 of	 three	modes	 from	 the	 doubly-multivariate	 CCA-ICA	 analyses	 across	 all	 IDPs	 and	 non-brain-657	
imaging	variables.	IDPs	are	listed	in	orange	and	non-brain-imaging	variables	in	black.	The	text	lists	show	the	variables	most	658	 strongly	associated	with	each	mode;	where	multiple	very	similar	 (and	highly	correlated)	non-imaging	variables	are	 found,	659	 only	the	most	significant	is	listed	here	for	brevity.	The	first	column	shows	the	weight	(strength	and	sign)	of	a	given	variable	in	660	 the	 ICA	mode,	 the	second	shows	the	(cross-subject)	percentage	variance	of	 the	data	explained	by	 this	mode,	and	 the	 third	661	 column	 shows	 the	 percentage	 variance	 explained	 in	 the	 data	 without	 the	 confounds	 first	 regressed	 out.	 Mode	 7	 links	662	 measures	of	bone	density,	brain	structure/tissue	volumes	and	cognitive	tests.	Mode	8	links	measures	of	blood	pressure	and	663	 alcohol	 intake	 to	 IDPs	 from	 the	 diffusion	 and	 functional	 connectivity	 data;	 two	 functional	 network	 connections	 strongly	664	 involved	 are	 displayed,	with	 the	 population	mean	 connection	 indicated	 by	 the	 bar	 connecting	 the	 two	 nodes	 forming	 the	665	 connection	 (red	 indicates	 positive	 mean	 correlation,	 blue	 negative,	 and	 the	 width	 of	 the	 bar	 indicates	 the	 connection	666	 strength).	The	group-ICA	maps	are	thresholded	at	Z>5,	and	the	colored	text	is	the	ICA	weight	shown	in	the	table	list.	Mode	9	667	 includes	a	wide	range	of	imaging	and	non-imaging	variables	(see	main	text	for	details);	as	well	as	showing	3	strong	functional	668	 network	connections,	we	also	show	two	functional	nodes	whose	resting	fluctuation	amplitude	is	associated	with	this	mode.	669	
Figure	 8	 	 	 Hypothesis-driven	 study	 of	 age,	 BMI	 and	 smoking	 associations	 with	 subcortical	 T2*.	 (a)	 UK	 Biobank	670	 population-average	 map	 of	 T2*,	 overlaid	 with	 the	 main	 subcortical	 structures	 being	 investigated.	 The	 T2*	 IDPs	 reflect	671	 individuals’	median	T2*	values	within	these	regions.	The	relatively	low	T2*	in	putamen	and	pallidum	likely	reflects	greater	672	 iron	content.	(b)	BMI	regression	betas	from	multiple	regressions	of	R2*	(from	the	ASPS	study)	and	T2*	(from	UK	Biobank)	673	 against	 relevant	 covariates	 (see	 (c)).	 All	 variables	 are	 standardized	 so	 that	 beta	 values	 can	 be	 interpreted	 as	 (partial)	674	 correlation	coefficients.	R2*	significance	is	reported	as	FDR-corrected	P.	T2*	significance	is	reported	as	–log10Puncorrected	with	675	 the	more	conservative	Bonferroni	correction	(for	Pcorrected=0.05)	resulting	in	a	threshold	here	of	3.6.	(c)	Full	set	of	univariate	676	 and	multiple	 regression	betas	and	 significance	values	 for	all	brain	 regions	 tested	and	all	model	 covariates.	The	 regression	677	 results	are	much	sparser,	reflecting	the	higher	associational	specificity	obtained	by	reporting	unique	variance	explained.	678	
	679	
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ONLINE	METHODS		680	
Protocol	Overview	681	 Imaging	 protocols	were	 designed	 by	 the	 UK	 Biobank	 Imaging	Working	 Group	 (www.ukbiobank.ac.uk/expert-682	 working-groups),	in	consultation	with	a	large	number	of	brain	imaging	experts	(listed	in	the	acknowledgments).	683	 MRI	 provides	 many	 imaging	 modalities	 offering	 complementary	 information.	 As	 part	 of	 this	 consultancy,	 a	684	 number	of	modalities	were	determined	to	be	infeasible	or	lower	priority	for	a	range	of	reasons.	Considerations	685	 included	time	constraints,	generalizability,	feasibility	of	automated	analysis,	and	existence	of		robust,	well-tested	686	 acquisition	 methods.	 The	 advisory	 network	 therefore	 decided	 not	 to	 include	 quantitative	 relaxometry,	 MR	687	 spectroscopy	or	angiography.	Arterial	spin	labeling	is	currently	being	piloted,	as	described	below.	688	 To	 maximize	 data	 compatibility,	 three	 dedicated	 imaging	 centers	 will	 have	 identical	 scanners	 with	 fixed	689	 platforms	(i.e.,	no	major	software	or	hardware	updates	throughout	the	study).	Each	center	is	equipped	with	a	3T	690	 Siemens	Skyra	(software	platform	VD13),	1.5T	Siemens	Aera	(VD13),	carotid	ultrasound	and	dual	energy	X-ray	691	 absorptiometry	(DEXA).	Brain	imaging	is	being	conducted	on	the	3T	system	using	a	32-channel	receive	head	coil.	692	 Key	acquisition	parameters	for	each	modality	are	summarized	in	Supplementary	Table	1,	grouped	according	to	693	 primary	modality	 categories	 (structural,	 diffusion	 and	 functional	MRI).	 Order	 of	 acquisition	was	 optimized	 in	694	 consideration	 of	 subject	 compliance,	 assuming	 subject	 motion	 might	 increase	 over	 the	 scan	 (favoring	 early	695	 acquisition	of	the	T1	due	to	its	central	importance	–	for	example	the	processing	pipeline	cannot	run	without	the	696	 T1)	and	subject	wakefulness	might	decrease	(favoring	early	acquisition	of	fMRI).	The	order	is:	(1)	T1,	(2)	resting	697	 fMRI,	(3)	task	fMRI,	(4)	T2	FLAIR,	(5)	dMRI,	(6)	swMRI.	698	 Further	 protocol	 details	 are	 available	 at:	 http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=2367	 and	 further	699	 description	 of	 post-processing	 pipelines	 and	 data	 outputs	 included	 in	 the	 first	 data	 release	 are	 available	 at:	700	 http://biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf.	All	software	used	in	these	pipelines	is	freely	available51,	701	 52	and	full	pipeline	processing	scripts	will	shortly	be	publicly	available.	702	 The	processing	pipeline	utilized	 for	 the	 initial	data	release	was	primarily	based	on	 tools	 from	FSL	(the	FMRIB	703	 Software	Library51),	but	it	will	be	gradually	expanded	to	utilize	a	broader	range	of	methods	and	software,	where	704	 this	will	increase	the	quality,	robustness	and	scope	of	IDPs	generated.	For	example,	one	high	priority	is	to	adapt	705	 the	Human	Connectome	Project	pipelines53	to	provide	cortical	surface	modeling.	706	 The	intention	is	that	non-imaging	experts	will	be	able	to	use	the	IDPs	directly	without	having	to	become	expert	707	 in	the	complexities	of	data	processing,	although	we	encourage	engagement	with	imaging	experts	in	light	of	the	708	 numerous	and	subtle	caveats	and	confounds	associated	with	interpreting	these	data.	709	 Data	access	requests	from	all	academic	or	commercial	researchers	(with	no	exclusive	or	preferential	access)	are	710	 processed	by	the	UK	Biobank’s	Research	Access	Administration	Team	and	approved	relatively	rapidly	provided	711	 that	they	fulfill	UK	Biobank’s	aims	of	supporting	health	research	in	the	public	interest.	Researchers’	institutions	712	 then	sign	a	Material	Transfer	Agreement	agreeing	not	to	attempt	to	 identify	any	participant,	and	to	return	any	713	 derived	data	(e.g.,	new	IDPs)	to	UK	Biobank,	to	be	made	available	to	other	approved	researchers	after	an	agreed	714	 “embargo”	period	(to	allow	findings	to	be	published	or	IP	protected	by	the	researchers).	Thus,	while	the	first	set	715	 of	IDPs	described	here	from	internally	commissioned	research	is	being	made	available	immediately,	the	range	of	716	 IDPs	is	expected	to	grow	rapidly	as	additional	contributions	from	the	wider	user	community	are	added.		717	
	718	
Protocol	Considerations	719	 Design	of	the	brain	imaging	protocol	was	conducted	through	broad	consultation	with	neuroimaging	experts	and	720	 required	careful	balance	of	a	range	of	considerations,	often	specifically	relating	to	the	high	throughput	nature	of	721	 UK	Biobank.	In	setting	up	the	pilot	protocol,	the	primary	challenge	was	to	achieve	the	target	of	one	participant	722	 scanned	 every	 36	 minutes	 without	 serious	 compromise	 to	 data	 quality	 compared	 to	 research	 protocols	 that	723	 might	 conventionally	 require	 up	 to	 an	 hour	 of	 scan	 time.	 Despite	 these	 tight	 time	 constraints,	 we	 aimed	 to	724	 include	 as	many	MRI	modalities	 as	 possible,	 to	 take	 advantage	 of	 the	 full	 richness	 of	 information	 that	 can	 be	725	 provided	by	MRI.	Here,	we	highlight	 the	primary	considerations	that	required	a	different	approach	 from	more	726	 conventional	imaging	studies.	727	
• With	 each	 additional	minute	 of	 scanning	 per	 subject	 effectively	 costing	 an	 additional	 ~£1million,	 there	 is	728	 enormous	 value	 associated	with	 seemingly	 small	 efficiency	 savings.	We	 recovered	 several	minutes	 of	 scan	729	 time	by	systematically	minimizing	 the	overheads	associated	with	subject	placement,	 scan	prescription,	and	730	 calibration	measurements.	For	example,	corrections	to	the	static	magnetic	field	homogeneity	(shimming)	and	731	 strict	enforcement	of	a	single	shim	calibration	harvested	2	minutes	(changing	system	defaults	to	improve	and	732	 accelerate	shimming),	which	is	equivalent	to	the	scan	time	associated	with	some	of	the	included	modalities.	733	
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• Tight	 imaging	 FOVs	 (fields	 of	 view	 –	 the	 physical	 size	 of	 the	 imaged	 volume)	 are	 in	 general	 favorable	 to	734	 reduce	scan	time;	however,	these	restrictions	exclude	subjects	with	larger	heads	or	brains.	For	UK	Biobank,	735	 even	a	 “conservative”	FOV	 that	 includes	99%	of	 the	population	will	 exclude	1000	participants.	As	detailed	736	 statistics	on	brain	size	(as	distinct	from	head	size)	were	not	available	in	the	literature,	we	conducted	a	study	737	 of	population	brain	size54	that	(in	conjunction	with	optimal	slice	angling)	enables	our	FOVs	to	target	99.9%.	738	
• It	 is	 critically	 important	 that	 all	 analyses	 are	 automated.	 This	 translates	 to	 an	 additional	 role	 for	 certain	739	 imaging	modalities	 beyond	 their	 intrinsic	 information	 content.	 Thus,	 although	we	 considered	methods	 for	740	 reducing	scan	time	for	T1-weighted	structural	scans	while	retaining	coverage	and	resolution	(e.g.,	elliptical	741	 sampling	with	consequent	image	blurring),	this	was	deemed	an	unacceptable	risk	given	the	central	role	of	the	742	 T1	 to	 cross-subject	 and	 cross-modal	 alignment	 for	most	 processing	 pipelines,	 including	 that	 implemented	743	 here	for	the	initial	data	release.	744	
• The	 EPI	 (echo-planar	 imaging)	 acquisitions	 for	 fMRI	 and	 dMRI	 result	 in	 significant	 image	 distortion	 that	745	 creates	local	misalignment	in	certain	brain	regions.	Correction	of	this	requires	measurement	of	the	magnetic	746	 field	 inhomogeneities	 that	 cause	 distortion.	 Two	 types	 of	measurements	 are	 possible:	 a	 non-EPI	 gradient-747	 echo	 acquisition	 with	 two	 echoes	 (conventional	 fieldmap)	 or	 two	 EPI-based	 spin	 echo	 acquisitions	 with	748	 opposite	phase	encode	direction55.	We	chose	the	latter,	which	can	be	incorporated	into	the	dMRI	protocol	as	749	 additional	b=0	scans	to	reduce	acquisition	time	(total	acquisition	time	~30s).	750	
• To	provide	data	with	as	rich	and	broad	a	range	of	applications	as	possible,	we	include	imaging	modalities	that	751	 are	 not	 yet	 widely	 used	 in	 clinical	 practice,	 such	 as	 fMRI	 and	 dMRI.	 These	modalities	 have	 demonstrated	752	 mechanistic	 and	 biological	 insights,	 and	 will	 hopefully	 see	 greater	 clinical	 take-up	 in	 the	 future,	 in	 part	753	 because	 of	 projects	 such	 as	 UK	 Biobank.	 We	 took	 advantage	 of	 recent	 advances	 in	 acquisition,	 largely	754	 developed	 as	 part	 of	 the	 Human	 Connectome	 Project,	 to	 obtain	 research	 quality	 data	 in	 limited	 time.	755	 Specifically,	 simultaneous	multi-slice	 (or	multiband,	MB)	 acquisitions56-59	 that	 enable	 rapid	 fMRI	 and	dMRI	756	 without	sacrificing	statistical	robustness	or	directions/b-values60,	respectively.	Without	these	accelerations,	a	757	 seven-minute	 dMRI	 scan	 of	 the	 same	 spatial	 resolution	would	 have	 been	 limited	 to	 ~32	 directions	 and	 a	758	 single	shell,	precluding	NODDI16	and	other	more	advanced	biological	modeling.	759	
• After	 early	 piloting,	 a	 clinical	 T2/PD-weighted	 acquisition	 was	 removed	 from	 the	 protocol.	 This	 decision	760	 reflected	 the	 limited	 relevance	 to	 UK	 Biobank	 goals	 (given	 the	 inclusion	 of	 the	 higher-quality	 and	 more	761	 biologically	informative	T2	FLAIR)	and	the	value	in	recovering	this	scan	time	(just	over	1	minute).	762	
• One	 shortcoming	 of	 the	 current	 protocol	 is	 the	 lack	 of	 a	 direct	 measure	 of	 neurovascular	 health.	We	 are	763	 piloting	 a	 protocol	 change	 to	 include	 a	 2-minute	 perfusion	 scan	 (using	 arterial	 spin	 labeling).	 This	 would	764	 require	reducing	task	fMRI	to	2	minutes;	while	this	is	an	extremely	short	task,	early	analyses	(using	truncated	765	 copies	of	existing	initial	tfMRI	datasets)	predict	that	it	will	be	sufficiently	robust.	766	
• A	major	ethical	question	in	studies	of	this	nature	relates	to	identification	and	handling	of	incidental	findings	767	 of	previously	unknown	pathology.	The	procedure	to	be	followed	in	UK	Biobank	has	been	considered	in	great	768	 depth	with	major	external	ethical,	legal	and	clinical	radiology	bodies,	and	with	the	funders	and	their	external	769	 review	 group.	 An	 assessment	 of	 different	 approaches	 to	 the	 identification	 of	 incidental	 findings	 and	 the	770	 impact	of	their	feedback	on	participants	and	the	health	service	has	been	conducted	as	part	of	the	pilot	phase	771	 of	UK	Biobank’s	imaging	project,	and	will	be	published	separately.	 	Based	on	its	results	and	the	deliberative	772	 process	undertaken	with	external	experts,	the	UK	Biobank	protocol	for	dealing	with	incidental	findings	does	773	 not	involve	the	routine	review	of	all	scans	for	potential	pathology	by	radiologists.	Instead,	if	a	radiographer	774	 incidentally	identifies	evidence	of	potentially	serious	pathology	(i.e.,	likely	to	threaten	life	span,	quality	of	life	775	 or	major	body	functions)	during	the	imaging	process	then	a	formal	radiologist	review	is	undertaken	and,	if	it	776	 is	confirmed	as	potentially	serious,	feedback	is	given	to	the	participant	and	their	doctor.	777	
• Informed	 consent	 is	 obtained	 from	 all	 UK	 Biobank	 participants;	 ethical	 procedures	 are	 controlled	 by	 a	778	 dedicated	 Ethics	 and	 Guidance	 Council	 (http://www.ukbiobank.ac.uk/ethics)	 that	 has	 developed	 with	 UK	779	 Biobank	 an	 Ethics	 and	 Governance	 Framework	 (given	 in	 full	 at	 http://www.ukbiobank.ac.uk/wp-780	 content/uploads/2011/05/EGF20082.pdf),	 with	 IRB	 approval	 also	 obtained	 from	 the	 North	 West	 Multi-781	 centre	Research	Ethics	Committee.	782	
• Subjects	 are	 excluded	 from	 scanning	 according	 to	 fairly	 standard	 MRI	 safety/quality	 criteria,	 such	 as	783	 exclusions	 for	metal	 implants,	 recent	 surgery,	 or	 health	 conditions	 directly	 problematic	 for	MRI	 scanning,	784	 such	as	problems	hearing,	breathing	or	extreme	claustrophobia.	785	
• Once	 the	 second	 and	 third	 imaging	 centers	 are	 complete	 and	 running,	 UK	 Biobank	 will	 use	 non-human	786	 phantom	objects	and	traveling	volunteers	to	confirm	quality	and	consistency	across	sites.	787	
	788	
Structural	Imaging	789	 The	 T1	 structural	 protocol	 is	 acquired	 at	 1mm	 isotropic	 resolution	 using	 a	 3D	 MPRAGE	 acquisition,	 with	790	 inversion	 and	 repetition	 times	 optimized	 for	 maximal	 contrast.	 The	 superior-inferior	 field-of-view	 is	 large	791	 (256mm),	at	little	cost,	in	order	to	include	reasonable	amounts	of	neck/mouth,	as	those	areas	will	be	of	interest	792	
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to	some	researchers	(for	example,	in	the	study	of	sleep	apnea).	Pre-processing	of	this	modality	included	removal	793	 of	the	face	(which	was	deemed	important	to	subject	anonymisation	for	the	standard	data	dissemination),	brain	794	 extraction	 (removal	 of	 non-brain	 tissues	 from	 the	 image),	 linear	 alignment	 to	 the	 standard	 MNI152	 brain	795	 template61	and	non-linear	warping	to	this	template62	to	maximize	correspondence	across	individuals	in	light	of	796	 significant	cross-subject	variation	in	brain	structure.	These	alignments	are	used	throughout	the	majority	of	the	797	 processing	pipeline	for	other	modalities.	798	 T1	images	are	further	analyzed	to	estimate	volumes	of	a	range	of	tissues	and	structures	in	each	subject,	which	799	 may	reflect	atrophy	due	 to	age	and	disease,	as	well	as	normal	variation	due	 to	 (e.g.)	use-dependent	plasticity.	800	 Images	 are	 segmented	 into	 tissue	 types	 (gray	matter,	white	matter	 and	 cerebro-spinal	 fluid)63.	 	 Cortical	 gray	801	 matter	 volume	 is	 estimated,	 comparing	 the	 segmented	 gray	matter	 to	 an	 atlas	 reference	 (where	 the	 external	802	 skull	 surface	 is	 used	 to	 normalize	 for	 head	 size)64.	 	 Sub-cortical	 volumes	 are	 estimated65,	 utilizing	 population	803	 priors	on	shape	and	 intensity	variation	across	subjects.	T1-based	IDPs	are	generated	for	the	volumes	of	major	804	 tissue	types	of	the	whole	brain	and	for	specific	structures	(primarily	sub-cortically).	805	 Too	much	reliance	on	spatial	registration	could	limit	the	usefulness	or	accuracy	of	some	IDPs.	This	is	in	part	why	806	 many	 of	 the	 IDPs	 are	 in	 fact	 generated	 from	within-subject	 analyses	 that	 do	 not	 depend	 on	 exact	 voxelwise	807	 spatial	alignment	to	standard	space	(or	between	subjects):	for	example,	283	of	the	715	structural	and	diffusion	808	 IDPs	do	not	rely	on	exact	spatial	alignment	and	are	carried	out	in	the	original	space	of	each	subjects’	data.	809	 The	 T2	 protocol	 uses	 a	 fluid-attenuated	 inversion	 recovery	 (FLAIR)	 contrast	 with	 the	 3D	 SPACE	 optimized	810	 readout66.	This	shows	strong	contrast	for	white	matter	hyperintensities.	An	automated	pipeline	for	delineating	811	 these	 hyperintensities	 is	 currently	 being	 developed	 and	 future	 data	 releases	 will	 include	 IDPs	 reflecting	 the	812	 lesion	“load”.	813	 The	 swMRI	 scan	 uses	 a	 3D	 gradient	 echo	 acquisition	 at	 0.8x0.8x3mm	 resolution,	 acquiring	 two	 echo	 times	814	 (TE=9.4	 and	 20	 ms).	 Anisotropic	 voxels	 can	 enhance	 certain	 contrast	 mechanisms,	 particularly	 for	 vascular	815	 conspicuity	due	to	through-plane	dephasing	effects,	but	are	less	ideal	for	other	susceptibility-based	processing.	816	 Ultimately,	however,	this	choice	was	motivated	by	the	desire	for	whole	brain	coverage	in	the	face	of	very	limited	817	 scan	time	(2.5	minutes).	Signal	decay	times	(T2*)	are	estimated	from	the	magnitude	images	at	the	two	TEs,	and	818	 the	generated	IDPs	are	the	median	T2*	estimated	within	the	various	subcortical	regions	delineated	from	the	T1	819	 processing.	Venograms	are	generated	through	non-linear	 filtering	of	 the	magnitude	and	phase	 images12,	which	820	 produces	 enhanced	 conspicuity	 of	 medium	 and	 large	 veins.	 Automated	 segmentation	 of	 microbleeds	 and	821	 venograms	would	 provide	 significant	 value,	 but	 to	 our	 knowledge	 robust	 tools	 for	 this	 are	 not	 yet	 available;	822	 future	pipeline	versions	can	hope	to	include	such	analyses.	Future	work	will	also	consider	whether	this	data	will	823	 support	quantitative	susceptibility	mapping,	which	would	provide	further	information	on	tissue	constituents	as	824	 discussed	in	the	main	text.		825	
	826	
Diffusion	Imaging	827	 Diffusion	 data	 is	 acquired	 with	 two	 b-values	 (b=1000	 and	 2000	 s/mm2)	 at	 2mm	 spatial	 resolution,	 with	828	 multiband	 acceleration	 factor	 of	 3	 (three	 slices	 are	 acquired	 simultaneously	 instead	 of	 just	 one).	 For	 each	829	 diffusion-weighted	 shell,	 50	 distinct	 diffusion-encoding	 directions	 were	 acquired	 (covering	 100	 distinct	830	 directions	over	the	two	b-values).	The	diffusion	preparation	is	a	standard	(“monopolar”)	Stejskal-Tanner	pulse	831	 sequence.	 This	 enables	 higher	 SNR	 due	 to	 a	 shorter	 echo	 time	 (TE=92ms)	 than	 a	 twice-refocused	 (“bipolar”)	832	 sequence	at	the	expense	of	stronger	eddy	current	distortions,	which	are	removed	using	the	Eddy	tool67	(which	833	 also	corrects	for	static	field	distortion	and	motion68).	834	 Both	diffusion	tensor	and	NODDI	models	are	fit	voxel-wise,	and	IDPs	of	the	various	model	outputs	are	extracted	835	 from	a	set	of	white	matter	tracts.	Tensor	fits	utilize	the	b=1000	s/mm2	data,	producing	maps	including	fractional	836	 anisotropy,	 tensor	 mode	 and	 mean	 diffusivity.	 The	 NODDI16	 model	 is	 fit	 using	 the	 AMICO	 (Accelerated	837	 Microstructure	 Imaging	 via	 Convex	Optimization)	 tool52,	with	 outputs	 including	 intra-cellular	 volume	 fraction	838	 (which	 is	 often	 interpreted	 to	 reflect	 neurite	 density)	 and	 orientation	 dispersion	 (a	measure	 of	 within-voxel	839	 disorganization).	 For	 tractography,	 a	 parametric	 approach	 is	 first	 used	 to	 estimate	 fibre	 orientations.	 The	840	 generalised	 ball	&	 stick	model	 is	 fit	 to	 the	multi-shell	 data,	 estimating	 up	 to	 3	 crossing	 fibre	 orientations	 per	841	 voxel.17,	69	Tractography	 is	 then	performed	 in	a	probabilistic	manner	 to	estimate	white	matter	pathways	using	842	 the	voxel-wise	orientations.	843	 Cross-subject	 alignment	 of	 white	 matter	 pathways	 is	 critical	 for	 extracting	 meaningful	 IDPs;	 here,	 two	844	 complementary	 approaches	 are	 used.	 The	 first	 used	 tract-based	 spatial	 statistics	 (TBSS18,	 70),	 in	 which	 a	845	 standard-space	white	matter	 skeleton	 is	mapped	 to	 each	 subject	 using	 a	 high-dimensional	warp,	 after	which	846	 ROIs	 are	 defined	 as	 the	 intersection	 of	 the	 skeleton	with	 standard-space	masks	 for	 48	 tracts71	 (see	 the	 “JHU	847	 ICBM-DTI-81	white-matter	 labels	atlas”	described	at	 fsl.fmrib.ox.ac.uk/fsl/fslwiki/Atlases	 for	definitions	of	 the	848	
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tract	regions	and	names).	The	second	approach	utilizes	subject-specific	probabilistic	diffusion	tractography	run	849	 using	standard-space	protocols	to	identify	identify	27	tracts18;	in	this	case,	the	output	IDPs	are	weighted	by	the	850	 tractography	 output	 to	 emphasize	 values	 in	 regions	 that	 can	 most	 confidently	 be	 attributed	 to	 the	 tract	 of	851	 interest.	 Currently,	 no	 structural	 connectivity	 estimates	 from	 the	diffusion	 tractography	 are	provided	 as	 IDPs,	852	 but	 the	probabilistic	maps	are	available	and	 future	work	will	generate	measures	similar	 to	 those	provided	 for	853	 resting-state	fMRI.	854	
	855	
Functional	MRI	856	 Task	and	resting-state	fMRI	use	the	same	acquisition	parameters,	with	2.4mm	spatial	resolution	and	TR=0.735s,	857	 with	 multiband	 acceleration	 factor	 of	 8.	 A	 “single-band”	 reference	 image	 (without	 the	 multiband	 excitation,	858	 exciting	 each	 slice	 independently)	 is	 acquired	 that	 has	 higher	 tissue-type	 image	 contrast;	 this	 is	 used	 as	 the	859	 target	 for	motion	 correction	 and	 alignment.	 For	 both	 data	 sets,	 the	 raw	 data	 are	 corrected	 for	motion72	 and	860	 distortion55	and	high-pass	filtered	to	remove	temporal	drift.		861	 The	task	scan	used	the	Hariri	 faces/shapes	“emotion”	 task21,	73,	as	 implemented	 in	 the	HCP22,,	but	with	shorter	862	 overall	duration	and	hence	fewer	total	stimulus	block	repeats.	The	participants	are	presented	with	blocks	of	face	863	 or	shape	trials	and	asked	to	decide	which	of	two	faces	(or	shapes)	presented	on	the	bottom	of	the	screen	match	864	 the	 face	 (or	 shape)	 at	 the	 top	 of	 the	 screen.	 The	 faces	 have	 either	 angry	 or	 fearful	 expressions.	 The	 ePrime	865	 stimulus	script	is	available	for	download	(http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=1462).	Task-induced	866	 activation	is	modeled	with	FEAT,	 including	auto-correlation	correction74,	using	5	activation	contrasts.	Of	these,	867	 the	 three	 activation	 contrasts	 of	 most	 interest	 (shapes,	 faces	 and	 faces>shapes)	 are	 used	 to	 generate	 output	868	 measures,	including	two	IDPs	for	the	faces-shapes	task	(one	including	all	voxels	above	a	group-level	fixed-effects	869	 Z>120,	and	one	including	only	the	amygdala	regions	above	threshold).	IDPs	corresponding	to	both	percent	signal	870	 change	and	statistical	significance	(Z	statistics)	are	generated.	871	 During	resting-state	scans,	subjects	are	instructed	to	keep	their	eyes	fixated	on	a	crosshair,	relax	and	“think	of	872	 nothing	 in	 particular”.	 Resting-state	 are	 identified	 using	 ICA	 (independent	 component	 analysis33,	 75),	 which	873	 identifies	 components	within	 the	data	 that	are	spatially	 independent	 (where	a	component	comprises	a	 spatial	874	 map	and	a	single	associated	time	course).	Following	the	pre-processing	described	above,	resting-state	fMRI	data	875	 for	 each	 subject	 is	 further	 “cleaned”	using	 an	 ICA-based	 algorithm	 for	 automatically	 identifying	 and	 removing	876	 structured	 artefacts76.	 This	 data	 is	 fed	 into	 group-level	 ICA	 (including	 an	 initial	 group-level	 dimensionality	877	 reduction77),	which	is	used	to	parcellate	the	data	set	into	sets	of	25	and	(separately)	100	spatially-independent	878	 components.	 Where	 a	 small	 (<30)	 number	 of	 components	 is	 estimated78,	 it	 is	 common	 to	 consider	 each	879	 component	as	a	separate	“network”	in	its	own	right;	each	component	will	often	include	several	non-contiguous	880	 regions,	 all	 having	 the	 same	 timecourse	 (according	 to	 the	 model).	 If	 a	 higher	 number	 of	 components	 is	881	 estimated79,	these	are	more	likely	to	be	smaller	regions	(parcels),	which	can	then	be	considered	as	nodes	for	use	882	 in	network	analysis80,	where	the	spatial	maps	are	used	to	define	subject-specific	time	courses	(the	first	stage	of	883	 dual	regression1).	These	time	courses	are	used	to	estimate	the	size	of	signal	fluctuation	in	each	node,	as	well	as	to	884	 estimate	 connectivity	 between	 pairs	 of	 nodes	 using	 L2-regularised	 partial	 correlation81.	 The	 connectivity	885	 estimates	are	provided	as	IDPs	at	both	parcellation	dimensionalities	(25	and	100	nodes);	after	removal	of	group-886	 ICA	 components	 considered	 to	 be	 artefactual	 (i.e.,	 relating	 either	 to	 scanning	 artefacts,	 or	 to	 non-neuronal	887	 biophysical	 processes	 such	 as	 cardiac	 fluctuations	 and	 head	motion),	 this	 results	 in	 21	 and	 (respectively)	 55	888	 nodes	left	for	forming	the	IDPs	such	as	network	matrices	(functional	connectivities	between	pairs	of	nodes).	889	
	890	
Quality	control	891	 To	date,	raw	data	and	pipeline	outputs	have	been	manually	checked	for	gross	problems	of	quality	and	robustness,	892	 with	problematic	data	 tagged	and	 removed	 from	pipeline	outputs;	 see	main	 text	 for	 results	on	proportions	of	893	 usable	data	in	the	different	modalities.	However	several	quality-related	IDPs	are	automatically	generated	by	the	894	 pipeline	 (for	 example,	 number	 of	 outlier	 slices	 in	 the	 dMRI	 data,	 and	measures	 of	 signal-to-noise	 ratio	 in	 the	895	 various	modalities),	and	these	can	be	used	to	help	automatically	 identify	problematic	data.	An	expanded	set	of	896	 such	 quality	 measures	 is	 being	 produced,	 in	 addition	 to	 an	 automated	 machine	 learning	 system	 for	 flagging	897	 problematic	data	on	the	basis	of	the	many	IDPs	and	quality	measures;	 future	versions	of	the	pipeline	and	data	898	 releases	will	benefit	from	the	results	of	these	ongoing	developments.	899	
	900	
Statistics	901	 The	two	sections	below	describe	the	statistical	analysis	carried	out	using	IDPs	and	non-brain-imaging	measures.	902	 As	 described	 below,	 univariate	 statistics	 were	 primarily	 carried	 out	 using	 Pearson	 correlation	 (though	 see	903	
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details	 below	 regarding	 Gaussian-distribution	 normalization	 and	 linear	 removal	 of	 confound	 effects)	 and	904	 multivariate	statistics	were	carried	out	using	a	combination	of	canonical	correlation	analysis	and	 independent	905	 component	analysis	(with	permutation	testing	used	to	identify	the	significant	number	of	components	estimable).	906	 As	discussed	 in	 the	main	 text,	 the	primary	 rationale	 for	 the	 size	 of	 the	 study	 is	 not	 to	 boost	 statistical	 power	907	 across	100,000	subjects,	but	rather	to	provide	prospective	imaging	data	suitable	for	discovering	early	markers	908	 and	 risk	 factors	 for	 as	 broad	 a	 set	 of	 diseases	 as	 possible,	 both	 rare	 and	 highly	 prevalent.	 Hence	 while	909	 calculations	have	been	made	 to	 estimate	 the	 expected	numbers	of	 subjects	developing	different	diseases	over	910	 coming	years	(see	introductory	section	of	main	text),	no	statistical	methods	were	used	to	pre-determine	sample	911	 sizes	for	any	one	specific	disease,	given	that	individual	disease	sample	sizes	are	not	prospectively	controlled,	and	912	 given	the	very	broad	expected	set	of	future	tests	between	different	imaging	measures	and	different	diseases	that	913	 will	be	ultimately	applied	from	this	prospective	long-term	resource.	Details	on	significance	testing	and	multiple	914	 comparison	corrections	are	included	in	the	two	sections	below.	A	Supplementary	Methods	Checklist	is	available.	915	
	916	
Simple	associations	between	brain	IDPs	and	other	measures		917	 We	report	 simple	correlation	analyses	between	each	of	 the	2501	brain	 IDPs	and	each	of	1100	other	variables	918	 extracted	 from	 the	UK	Biobank	 database	 (these	 other	 variables	 are	mostly	 not	 derived	 from	 imaging,	 though	919	 some	do	come	from	the	non-brain	imaging	modalities);	for	the	list	of	general	classes	of	these	variables,	see	Fig.	920	
6a,	and	for	many	examples	of	individual	variables,	see	the	lists	associated	with	the	CCA-ICA	modes	presented	in	921	
Fig.	 7	 and	 Supplementary	 Figs.	 The	 initial	 set	 of	 variables	 extracted	 from	 the	 UK	 Biobank	 database	 was	922	 automatically	 reduced	 to	 those	 (1100	 variables)	 containing	 sufficient	 numbers	 of	 valid	 (non-missing)	 data	923	 entries,	 using	 very	 similar	 selection	 rules	 to	 those	 applied	 in	 the	 recent	 CCA-based	 analysis	 of	 Human	924	 Connectome	Project	data34.	 Some	variables	 are	defined	 (in	 the	UK	Biobank	database)	 such	 that	 the	numerical	925	 encoding	is	the	inverse	of	what	one	might	naturally	assume	-	for	example	in	the	variable	"Qualifications",	higher	926	 numbers	refer	 to	 lower	 levels	of	educational	qualifications.	 In	such	cases	we	have	 inverted	the	sign	of	 the	 ICA	927	 weightings	printed	in	the	figures,	for	ease	of	interpretation.	Further,	some	variables	are	categorical,	with	no	clear	928	 quantitative	meaning	to	the	values	(e.g.,	“Transport	type	to	work”);	where	we	find	an	apparent	association,	this	929	 can	be	 considered	 to	be	 indicative	of	 a	 real	 association	 (one	might	 think	of	 the	 analysis	 therefore	 as	 an	over-930	 conservative	poor	implementation	of	an	ANOVA),	but	interpretation	of	the	sign	of	the	association	clearly	needs	931	 care.	The	analysis	used	data	from	the	first	5430	subjects	scanned	and	having	usable	imaging	data:	age	range	44-932	 78y	(IQR	56-68y);	53%	of	subjects	were	female.	933	 Eight	 confound	 variables	 are	 generated:	 age,	 age2,	 sex,	 age×sex,	 age2×sex,	 average	 head	motion	 during	 tfMRI,	934	 average	head	motion	during	rfMRI	and	head	size.	To	enforce	Gaussianity,	all	confound	variables,	IDPs	and	non-935	 IDP	 variables	 are	 first	 passed	 through	 a	 rank-based	 inverse	 Gaussian	 transformation;	 this	 improves	 the	936	 robustness	of	correlations	(for	example,	to	avoid	undue	influence	of	potential	outlier	values).	The	confounds	are	937	 then	regressed	out	of	all	IDPs	and	non-IDP	variables	to	reduce	the	risk	of	finding	non-meaningful	associations.	938	 For	example,	head	motion	corrupts	imaging	data	in	complex	ways26,	and	also	correlates	with	some	diseases	and	939	 with	aging	(r=0.15	in	this	data);	hence,	if	not	adjusted	for,	uninteresting	associations	would	likely	arise.	However,	940	 some	measures	may	have	both	biologically	interesting	associations	with	IDPs,	and	also	act	as	imaging	confounds.	941	 For	example,	abnormal	heart	rate	or	blood	pressure	could	alter	the	fMRI	signal	through	disrupted	cerebral	auto-942	 regulation	(independent	of	any	changes	to	neural	activity)40,	but	cardiovascular	pathology	could	also	be	related	943	 to	 neurological	 pathology.	 Similarly,	 overall	 brain	 size	 and	 gray	 matter	 thickness	 IDPs	 are	 sensitive	 simple	944	 markers	of	aging	and	disease;	however,	 these	properties	can	also	affect	other	IDPs	by	changing	the	mixture	of	945	 tissue	types	in	an	imaging	voxel,	creating	an	apparent	age/disease	dependence	that	 is	driven	by	the	volume	of	946	 tissue	rather	than	the	properties	of	a	given	tissue	type	(such	as	fMRI	activation	or	white	matter	microstructural	947	 properties).	It	is	therefore	important	to	interpret	apparent	associations	carefully.	948	 The	 full	 set	 of	 2.8	 million	 (2501×1100)	 Pearson	 correlations	 is	 then	 estimated	 and	 corrected	 for	 multiple	949	 comparisons.	Bonferroni	correction,	which	is	likely	to	be	somewhat	conservative	in	such	situations,	due	to	non-950	 independence	across	variables	tested,	resulted	in	pcorrected<0.05	being	equivalent	to	requiring	puncorrected<1.8×10-8.	951	 An	alternative	popular	approach	for	multiple	comparison	correction	is	false	discovery	rate	(FDR);82	we	use	the	952	 more	conservative	FDR	option	(making	no	assumption	of	variable	dependencies83),	resulting	here	 in	requiring	953	 puncorrected<3.8×10-5.	These	 two	 threshold	 levels	are	shown	with	dotted	 lines	 in	all	Manhattan	plots	 in	 the	main	954	 figures.	955	
	956	
Multivariate	associations	between	brain	IDPs	and	other	measures	957	 In	 the	example	multivariate	analyses	shown	 in	Figs	7-8,	 canonical	correlation	analysis	 (CCA32)	combined	with	958	 independent	component	analysis	(ICA33)	is	used	to	identify	several	“modes”	of	population	covariation	which	link	959	 multiple	brain	IDPs	to	sets	of	other	Biobank	variables.	This	is	very	similar	to	the	methodology	used	recently	to	960	
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identify	a	single	mode	of	population	covariation	between	 imaging	measures	and	many	behavioral	and	 lifestyle	961	 measures	in	data	from	461	subjects	in	the	Human	Connectome	Project8,	34.	962	 IDP	and	non-IDP	variables	are	prepared	as	for	the	univariate	correlation	analyses	described	above,	resulting	in	a	963	 brain-IDP	matrix	of	size	5034×2501	(subjects	×	IDPs)	and	a	non-IDP	matrix	of	size	5034×1100	(subjects	×	non-964	 IDP	 variables).	 The	 intention	 is	 to	 feed	 these	 into	 CCA	 in	 order	 to	 identify	 population	modes	 linking	multiple	965	 variables	from	both	matrices.	However,	in	order	to	avoid	an	over-determined	(rank	deficient)	CCA	solution,	we	966	 first	compress	both	matrices	along	the	respective	phenotype	dimension	to	200	columns	(i.e.,	much	smaller	than	967	 the	numbers	of	subjects).	This	was	done	by	separately	reducing	each	matrix	to	the	top	200	subject-eigenvectors	968	 using	PCA.	To	achieve	this	while	avoiding	the	problem	of	missing	data,	we	use	the	approach	detailed	recently34	of	969	 estimating	first	a	pseudo-covariance	matrix	ignoring	missing	data,	projecting	this	onto	the	nearest	valid	(positive	970	 definite)	covariance	matrix,	and	 then	carry	out	an	eigenvalue	decomposition.	The	 two	resulting	(IDP	and	non-971	 IDP)	matrices	of	 size	5034×200	are	 then	 fed	 into	 standard	CCA	 (“canoncorr”	 in	Matlab),	 resulting	 in	200	CCA	972	 modes	being	estimated.	The	CCA	aims	to	identify	symmetric	linear	relations	between	the	two	sets	of	variables.	973	 Each	significant	CCA	mode	identifies	a	linear	combination	of	IDPs	and	a	linear	combination	of	non-IDPs,	where	974	 the	variation	in	mode	strength	across	subjects	is	maximally	correlated.	That	is,	CCA	finds	modes	that	relate	sets	975	 of	brain	measures	to	sets	of	subjects’	non-brain-imaging	measures;	for	a	graphical	illustration	of	this	approach,	976	 see	Smith	et	al34	(Supplementary	information).	977	 Permutation	testing	is	then	applied	to	estimate	(family-wise-error,	multiple-comparison-corrected)	p-values	for	978	 the	CCA	modes	estimated.	Nine	modes	are	 found	 to	be	significant	 (Pcorrected<0.002,	with	all	 later	modes	having	979	 Pcorrected>0.05).	 Because	 CCA	 can	 in	 general	 only	 unambiguously	 estimate	 distinct	modes	 up	 to	 an	 orthogonal	980	 rotation	amongst	 them	(by	direct	analogy	 to	PCA),	we	 identify	a	non-ambiguous	unmixing	of	 the	modes	using	981	 ICA	 to	optimize	 the	 final	 set	of	modes	 reported.	Because	we	expect	meaningful	population	modes	 to	be	much	982	 more	structured	(for	example,	sparser)	in	the	cross-variable	dimension	than	in	the	cross-subject	dimension,	we	983	 calculate	ICA	components	that	are	statistically	independent	from	each	other	in	the	cross-variable	dimension.	In	984	 order	 to	 take	 full	 advantage	 of	 the	 numbers	 of	 variables	 originally	 prepared,	 we	 first	 multiply	 the	 nine	 CCA	985	 subject-weight	 vectors	 into	 the	 original	 IDP	 and	 non-IDP	 data	 matrices	 (after	 concatenating	 these	 across	986	 variables),	resulting	in	nine	CCA	variable-weight	vectors	of	length	2501+1100=3601.	These	nine	vectors	are	then	987	 fed	 into	FastICA33	 in	order	 to	 estimate	nine	population	data	 sources	having	maximal	 statistical	 independence.	988	 This	general	approach	(CCA,	followed	by	concatenation	of	CCA	weight	vectors,	followed	by	ICA)	is	similar	to	that	989	 proposed	by	Sui84,	except	that	we	return	to	the	full	feature	space	(as	described	above)	for	the	ICA	stage,	rather	990	 than	 staying	 in	 the	 PCA-reduced	 space.	 The	 ICA	 result	 is	 extremely	 robust,	 with	 split-half	 (cross-subjects)	991	 reproducibility	across	the	9	ICA	components	of	r>0.89.	Interestingly,	5	of	these	ICA	modes	(including	modes	7,	8	992	 and	9,	shown	in	Fig.	7)	are	virtually	unchanged	if	the	de-confounding	step	was	omitted	(correlation	of	variable-993	 weights	vectors:	r>0.8).	994	
	995	
Data,	code	and	results	availability	996	 As	 described	 above,	 all	 source	 data	 (including	 raw	 and	processed	 brain	 imaging	 data,	 derived	 IDPs,	 and	non-997	 imaging	 measures)	 is	 available	 from	 UK	 Biobank	 via	 their	 standard	 data	 access	 procedure	 (see	998	 www.ukbiobank.ac.uk/register-apply).		999	 The	 image	 processing	 pipeline	 will	 be	 made	 publicly	 available	 in	 early	 2017	 from	1000	 www.fmrib.ox.ac.uk/ukbiobank	 -	 this	 is	 the	pipeline	used	 to	process	 the	 raw	 imaging	data	and	generate	 IDPs,	1001	 and	hence	is	not	needed	in	order	to	replicate	the	results	of	this	paper,	which	could	be	achieved	by	accessing	IDPs	1002	 as	described	above,	and	then	using	the	IDP	analysis	code	described	below.		1003	 The	Matlab	code	for	the	univariate	and	multivariate	tests	described	in	this	paper,	and	the	results	of	those	tests	1004	 (all	univariate	correlations	and	multivariate	weight	vectors)	are	available	from	www.fmrib.ox.ac.uk/ukbiobank	-	1005	 this	online	resource	will	be	updated	as	more	subjects’	data	and	more	IDPs	become	available.	1006	 	1007	
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		6.9		3		8	T1	FIRST	right	putamen	volume	
	-6.8		7	55	dMRI	TBSS	L3	Body	of	corpus	callosum	
		6.8		4	46	dMRI	TBSS	FA	Posterior	corona	radiata	L	
		6.8		7	55	dMRI	TBSS	ICVF	Posterior	corona	radiata	R	
		6.8		5	55	dMRI	TBSS	ICVF	Genu	of	corpus	callosum	
		6.7		5	40	dMRI	TBSS	FA	Cingulum	cingulate	gyrus	L	
		6.7		6	67	dMRI	ProbtrackX	ICVF	Sup	long	fascic	L	
		6.7		6	39	dMRI	TBSS	FA	Fornix	crus+Stria	term	R	
		6.7		5	55	dMRI	ProbtrackX	FA	forceps	minor	
		6.6		6	61	dMRI	TBSS	ICVF	Sup	long	fascic	L	
		6.6		5	66	dMRI	ProbtrackX	ICVF	Inf	long	fascic	L	
	-6.5		7	53	dMRI	TBSS	L2	External	capsule	R	
		6.5		6	70	dMRI	TBSS	ICVF	Anterior	corona	radiata	R	
	-6.5		5		8	dMRI	TBSS	OD	Body	of	corpus	callosum	
	-6.5		5	55	dMRI	TBSS	L3	Splenium	of	corpus	callosum	
	-6.4		4	15	dMRI	ProbtrackX	L3	Parahipp	cingulum	r	
	-6.4		4		7	dMRI	TBSS	OD	Cingulum	cingulate	gyrus	L	
		6.4		6	68	dMRI	TBSS	ICVF	External	capsule	R	
		6.4		7		4	Forced	expiratory	volume	in	1-second	
		6.4		5	70	dMRI	ProbtrackX	ICVF	Inf	front-occ	fasc	L	
	-6.4		6	49	dMRI	TBSS	L2	External	capsule	L	
	-6.4		6	69	dMRI	ProbtrackX	L3	Inf	front-occ	fasc	L	
		6.4		5	57	dMRI	ProbtrackX	ICVF	Acustic	radiation	L	
		6.3		6	67	dMRI	TBSS	ICVF	External	capsule	L	
	-6.3		6	11	Duration	to	complete	alphanumeric	path	
	-6.2		6	49	dMRI	ProbtrackX	L3	Uncinate	fasciculus	r	
		6.2		4	20	dMRI	TBSS	FA	Sup	cerebellar	peduncle	L	
		6.2		5	47	dMRI	TBSS	ICVF	Splenium	corpus	callosum	
		6.2		5	38	dMRI	TBSS	FA	Ant	limb	of	int	capsule	L	
	-6.2		7	60	dMRI	TBSS	L3	Posterior	corona	radiata	L	
		6.2		2	24	dMRI	ProbtrackX	FA	Acoustic	radiation	L	
	-6.2		5	50	dMRI	TBSS	L3	External	capsule	L	
	-6.2		4	16	dMRI	ProbtrackX	L2	Parahipp	cingulum	R	
	-6.2		6	65	dMRI	ProbtrackX	L3	Inf	long	fascic	L	
	-6.1		6	52	dMRI	TBSS	L3	External	capsule	R	
	-6.1		7	66	dMRI	ProbtrackX	L3	Ant	thal	radiation	R	
		6.1		7	52	dMRI	TBSS	ICVF	Sup	front-occ	fasc	R	
		6.1		6	69	dMRI	TBSS	ICVF	Anterior	corona	radiata	L	
		6.0		4	44	dMRI	TBSS	ICVF	Uncinate	fasciculus	R	
		6.0		5	34	dMRI	TBSS	FA	Ant	limb	of	int	capsule	R	
		6.0		3	37	dMRI	TBSS	FA	Posterior	corona	radiata	R	
		6.0		5	65	dMRI	ProbtrackX	ICVF	Inf	long	fascic	R	
		6.0		5	34	dMRI	TBSS	FA	Fornix	crus+Stria	term	L	
	-6.0		6		8	Time	to	complete	round
		ICA	%	%raw											CCA-ICA	mode	9	
	12.7	17	15	Fluid	intelligence	score	
		9.3	12	10	Age	completed	full	time	education	
		8.8	10	10	Qualifications	
	-7.7		7		5	Time	spent	watching	television	
	-7.7		8		5	tfMRI	90th-percentile	zstat	shapes	
	-7.6		6		6	Job	involves	heavy	manual	or	physical	work	
	-7.5		6		5	Time	spend	outdoors	in	summer	
		7.5		8		5	Cheese	intake	
	-7.4		3		1	Head	bone	mineral	content	
	-7.3		5		8	Job	involves	mainly	walking	or	standing	
	-7.1		5	19	Duration	to	complete	alphanumeric	path	
	-6.9		6		7	tfMRI	median	BOLD	shapes	
	-6.9		6		7	tfMRI	90th-percentile	BOLD	shapes	
	-6.7		6		5	tfMRI	median	zstat	shapes	
	-6.6		5		3	Time	spent	outdoors	in	winter	
	-6.5		5		3	Frequency	of	travelling	from	home	to	job	
		6.3		4		2	rfMRI	connectivity	(ICA100	edge	177)	
	-5.8		2		0	Head	bone	mineral	density	
	-5.7		3	18	Duration	to	complete	numeric	path	
		5.6		4	13	Number	of	symbol	digit	matches	attempted	
		5.5		3		3	Childhood	sunburn	occasions	
		5.4		4	12	Number	of	symbol	digit	matches	correct	
	-5.3		3		1	Type	of	fat/oil	used	in	cooking	
		5.2		2		2	Spreads/sauces	consumers	
	-5.1		4		2	tfMRI	90th-percentile	zstat	faces	
		5.1		2		2	Time	spent	using	computer	
	-5.1		3		0	Time	spent	driving	
	-5.0		2		1	Maternal	smoking	around	birth	
		5.0		3		5	Maximum	digits	remembered	correctly	
		4.9		1	10	T1	SIENAX	CSF	unnormalised	volume	
	-4.9		3		3	rfMRI	amplitudes	(ICA100	node	6)	
		4.9		1		8	T1	SIENAX	CSF	normalised	volume	
	-4.8		3		3	tfMRI	median	zstat	faces	
	-4.7		3		4	tfMRI	median	BOLD	faces	
		4.7		3		1	Never	eat	eggs,	dairy,	wheat,	sugar	
		4.7		1		6	T1	SIENAX	brain-unnormalised	volume	
		4.6		3	11	dMRI	TBSS	ISOVF	Sup	cerebellar	peduncle	R	
	-4.5		1		0	SWI	T2*	left	hippocampus	
	-4.5		2		1	rfMRI	connectivity	(ICA100	edge	345)	
		4.4		1		1	Handedness	
		4.4		1		7	T1	SIENAX	white	unnormalised	volume	
		4.4		1		0	T1	SIENAX	white	normalised	volume	
		4.4		1		0	T1	SIENAX	brain-normalised	volume	
		4.4		4	13	dMRI	TBSS	L1	Sup	cerebellar	peduncle	L	
	-4.3		2		1	Exposure	to	tobacco	smoke	outside	home	
	-4.3		2		0	Ease	of	getting	up	in	morning	
		4.3		3	10	dMRI	TBSS	ISOVF	Sup	cerebellar	peduncle	L	
		4.3		3	15	dMRI	TBSS	MD	Sup	cerebellar	peduncle	R	
		4.3		2		2	Age	started	smoking	in	former	smokers	
		4.2		3	14	dMRI	TBSS	MD	Sup	cerebellar	peduncle	L	
	-4.2		2		6	Time	to	complete	round	
		4.2		2		3	T1	FIRST	right	thalamus	volume	
		4.1		2		4	T1	FIRST	left	putamen	volume	
		4.1		2		2	Place	of	birth	in	UK	-	east	co-ordinate	
		4.1		3	14	dMRI	TBSS	L1	Sup	cerebellar	peduncle	R	
	-4.1		2		3	tfMRI	90th-percentile	BOLD	faces	
		4.1		2		2	rfMRI	connectivity	(ICA100	edge	534)	
		4.1		2		1	Dried	fruit	intake	
	-4.1		1		3	Duration	of	walks	
		4.0		2		3	T1	FIRST	left	pallidum	volume	
	-4.0		1		3	Duration	of	moderate	activity	
	-4.0		2		3	rfMRI	amplitudes	(ICA100	node	20)	
	-4.0		1		0	Yogurt	intake
a b c
ICA100 network connectivity - mode 8
ICA100 network connectivity - mode 9
ICA100 node amplitudes - mode 9
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															ASPS														UK	Biobank	
									R2*-BMI	regression			T2*-BMI	regression	
													beta	-log10PFDR						beta	-log10Puncorr	
Thalamus						0.029		0								L	-0.0239			0.7	
																														R	-0.0187			0.5	
Caudate							0.046		0								L	-0.0789			4.5	
																														R	-0.0746			4.1	
Putamen							0.044		0								L	-0.0570			2.6	
																														R	-0.0649			3.2	
Pallidum					-0.002		0								L	-0.0661			3.2	
																														R	-0.0772			4.1	
Hippocampus			0.135		>4.0					L	-0.1390		14.2	
																														R	-0.1343		13.7	
																											MEAN	-0.1490		17.0	
Amygdala						0.232		2.0						L	-0.0786			4.6	
																														R	-0.0478			2.0	
																											MEAN	-0.0701			3.9	
Accumbens				-0.048		0								L	-0.0117			0.2	
																														R	-0.0040			0.1
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		ICA	%	%raw											CCA-ICA	mode	1	
	17.5	30	58	Standing	height	
	14.3	22	45	Legs	combined	bone	area	
	14.3	23	45	L1-L4	area	
	12.6	14	39	Arms	combined	bone	area	
	12.6	11	16	Head	bone	mineral	content	
	11.4	15	53	Forced	vital	capacity	
	11.2	25	52	Trunk	fat-free	mass	
		9.8	25	48	Basal	metabolic	rate	
	-9.7		8	10	dMRI	ProbtrackX	OD	Medial	lemniscus	L	
		9.7	13	25	dMRI	TBSS	FA	Medial	lemniscus	L	
	-9.7		9	12	dMRI	ProbtrackX	OD	Medial	lemniscus	R	
	-9.7		8	10	dMRI	TBSS	OD	Medial	lemniscus	L	
		9.6	23	48	Leg	fat-free	mass	
		9.5	24	38	Body	surface	area	
		9.5	16	44	Total	bone	mineral	content	
	-9.5	11		3	T1	SIENAX	CSF	unnormalised	volume	
	-9.5	11		8	T1	SIENAX	CSF	normalised	volume	
		9.4	12	25	dMRI	TBSS	FA	Medial	lemniscus	R	
	-9.2		3	15	T1	SIENAX	brain	unnormalised	volume	
	-9.2		3		1	T1	SIENAX	brain	normalised	volume	
		9.2	20	40	Whole	body	water	mass	
	-8.9		2	13	T1	SIENAX	grey	unnormalised	volume	
	-8.9		7	11	dMRI	TBSS	OD	Medial	lemniscus	R	
	-8.9		2		0	T1	SIENAX	grey	normalised	volume	
	-8.6		1	14	T1	SIENAX	periph	grey	unnormalised	volume	
	-8.5		1		0	T1	SIENAX	periph	grey	normalised	volume	
		8.0		7		6	dMRI	ProbtrackX	MO	Medial	lemniscus	R	
		7.6		6		6	dMRI	ProbtrackX	MO	Medial	lemniscus	L	
	-7.5		8	10	dMRI	TBSS	L1	Fornix	
	-7.4		8	10	dMRI	TBSS	MD	Fornix	
	-7.3		7	10	dMRI	TBSS	L2	Fornix	
	-7.2		2		1	rfMRI	amplitudes	(ICA100	node	46)	
	-7.1		7		9	dMRI	TBSS	ISOVF	Fornix	
	-7.1		7	10	dMRI	TBSS	L3	Fornix	
		7.1		8		9	dMRI	TBSS	OD	Posterior	corona	radiata	R	
	-6.6		8	19	dMRI	TBSS	L1	Posterior	corona	radiata	R	
	-6.4		2	14	T1	SIENAX	white	unnormalised	volume	
	-6.4		6	13	dMRI	TBSS	L2	Medial	lemniscus	L	
	-6.4		2		4	T1	SIENAX	white	normalised	volume	
	-6.4		7	13	dMRI	TBSS	L2	Medial	lemniscus	R	
	-6.4		0	25	Leg	fat	percentage	
	-6.0		0		6	Trunk	tissue	fat	percentage	
	-6.0		7	26	dMRI	ProbtrackX	L1	sup	thal	radiation	L	
	-6.0		7	27	dMRI	ProbtrackX	L1	sup	thal	radiation	R	
	-6.0		4		4	dMRI	TBSS	OD	Fornix	
		5.8		5	10	dMRI	TBSS	FA	Fornix	
	-5.7		6	19	dMRI	TBSS	L1	Superior	corona	radiata	R	
	-5.7		3		4	rfMRI	connectivity	(ICA100	edge	995)	
		5.6		6	38	Hand	grip	strength	
		5.6		5		6	dMRI	TBSS	OD	Posterior	corona	radiata	L	
	-5.6		6	16	dMRI	TBSS	L1	Posterior	corona	radiata	L	
	-5.5		3		7	dMRI	TBSS	OD	Inferior	cerebellar	pedunc	L	
		5.5		4		3	dMRI	TBSS	MO	Medial	lemniscus	R	
	-5.4		2		6	dMRI	TBSS	OD	Cerebral	peduncle	R	
		5.4		4	24	LV	end	systolic	volume	
		5.4	14	23	Weight	
		5.3		4		2	dMRI	TBSS	MO	Medial	lemniscus	L	
	-5.3		4		3	dMRI	TBSS	MO	Posterior	corona	radiata	R	
		5.2		2		2	dMRI	TBSS	L1	Medial	lemniscus	R	
	-5.1		2		3	rfMRI	connectivity	(ICA100	edge	1014)	
	-5.1		5	23	dMRI	TBSS	MD	Sup	fronto-occipital	fasc	L	
	-5.0		6	27	dMRI_TBSS	MD	Superior	corona	radiata	R	
	-5.0		2		1	White	Blood	Cell	Count	
		5.0		4		5	dMRI_ProbtrackX_OD_str_r	
	-5.0		5	23	dMRI	TBSS	MD	Sup	fronto-occipital	fasc	R	
		4.9		1		0	dMRI	ProbtrackX	L1	Medial	lemniscus	R	
	-4.8		0		0	Body	mass	index
		ICA	%	%raw											CCA-ICA	mode	2	
	21.4	46	43	Head	bone	mineral	density	
	20.0	40	41	Head	bone	mineral	content	
	18.7	47	79	Total	bone	mineral	density	
	13.1	31	58	Total	bone	mineral	content	
	10.8	20	50	Android	bone	mass	
		9.1	13	17	T1	SIENAX	perip	grey	unnormalised	volume	
		8.8	13		6	T1_SIENAX	periph	grey	normalised	volume	
		8.6	18	52	Gynoid	bone	mass	
		8.0	14	41	Arms	bone	mineral	content	
		7.5		9	19	dMRI	TBSS	FA	Corticospinal	tract	R	
	-7.4		9	18	dMRI	TBSS	L2	Corticospinal	tract	R	
		7.4	14	45	Legs	bone	mineral	content	
	-7.2		8	15	dMRI	TBSS	L1	Pontine	crossing	tract	
	-7.0		5	10	dMRI	TBSS	OD	Corticospinal	tract	R	
	-6.7		4		2	T1	FIRST	brainstem+4th	ventricle	volume	
		6.5		7	15	T1	SIENAX	grey	unnormalised	volume	
		6.4		7		3	T1	SIENAX	grey	normalised	volume	
	-6.3		7	16	dMRI	TBSS	MD	Pontine	crossing	tract	
	-6.3		6	16	dMRI	TBSS	L3	Corticospinal	tract	R	
		6.2		5	17	dMRI	ProbtrackX	FA	Corticospinal	tract	R	
		6.0		3		1	SWI	T2*	right	amygdala	
	-5.9		6	11	dMRI	TBSS	ISOVF	Pontine	crossing	tract	
	-5.7		6	14	dMRI	TBSS	L2	Corticospinal	tract	L	
	-5.5		7	19	dMRI	TBSS	L2	Middle	cerebellar	peduncle	
	-5.4		3		7	dMRI	TBSS	OD	Corticospinal	tract	L	
		5.3		5	14	dMRI	TBSS	FA	Corticospinal	tract	L	
	-5.2		6		3	T1	SIENAX	CSF	normalised	volume	
		5.2		1		1	SWI	T2*	left	amygdala	
	-5.2		5		1	T1	SIENAX	CSF	unnormalised	volume	
	-5.2		4	11	dMRI	TBSS	L2	Pontine	crossing	tract	
		5.2		4		6	dMRI	TBSS	MO	Middle	cerebellar	peduncle	
	-5.2		2		6	dMRI	ProbtrackX	OD	Corticospinal	tract	R	
		5.1		3		4	dMRI	ProbtrackX	MO	Corticospinal	tract	R	
	-5.1		0	10	Legs	bone	area	
	-5.1		4	11	dMRI	TBSS	MD	Corticospinal	tract	R	
		5.0		4		5	dMRI	TBSS	MO	Corticospinal	tract	R	
	-5.0		4		7	dMRI	TBSS	ISOVF	Corticospinal	tract	R	
	-4.9		5	14	dMRI	TBSS	L3	Pontine	crossing	tract	
		4.9		3		7	dMRI	ProbtrackX	MO	Middle	cerebellar	ped	
	-4.8		4	13	dMRI	TBSS	L3	Corticospinal	tract	L	
		4.7		1		0	dMRI	ProbtrackX	L3	Middle	cerebellar	ped	
		4.7		3		1	dMRI	TBSS	MO	Inferior	cerebellar	ped	L	
		4.6		4	16	dMRI	TBSS	FA	Middle	cerebellar	peduncle	
	-4.6		2		0	dMRI	ProbtrackX	FA	Parahipp	cingulum	R	
	-4.5		4	10	dMRI	TBSS	L2	Inferior	cerebellar	ped	L	
	-4.5		1		5	dMRI	TBSS	OD	Middle	cerebellar	peduncle	
		4.5		3		0	dMRI	ProbtrackX	OD	Parahipp	cingulum	R	
	-4.4		5	11	dMRI	TBSS	L2	Inferior	cerebellar	ped	R	
		4.4		3	11	dMRI	ProbtrackX	FA	Corticospinal	tract	L	
		4.3		2	13	T1	SIENAX	brain-unnormalised	volume	
	-4.3		5	18	dMRI	TBSS	L3	Middle	cerebellar	peduncle	
		4.3		1		1	dMRI	ProbtrackX	MD	Middle	cerebellar	ped	
		4.2		2		3	Type	of	fat/oil	used	in	cooking	
	-4.2		1		0	Birth	weight	
		4.2		5		5	rfMRI	amplitudes	(ICA100	node	53)	
		4.1		2		4	T1	SIENAX	brain	normalised	volume	
		4.0		1		2	dMRI	ProbtrackX	ISOVF	Mid	cerebellar	ped	
		4.0		2		1	dMRI	TBSS	MO	Inferior	cerebellar	ped	R	
		4.0		1		2	SWI	T2*	left	accumbens	
		4.0		1		2	dMRI	ProbtrackX	L1	Mid	cerebellar	ped	
	-4.0		5	14	dMRI	TBSS	MD	Middle	cerebellar	peduncle	
	-3.9		4		3	dMRI	TBSS	L1	Fornix	
	-3.9		3	10	dMRI	TBSS	MD	Medial	lemniscus	L	
	-3.9		4		8	dMRI	TBSS	ISOVF	Mid	cerebellar	peduncle
		ICA	%	%raw											CCA-ICA	mode	3	
-15.9	49	75	Arms	fat	mass	
-15.8	49	35	Legs	fat	mass	
-15.6	48	81	Body	mass	index	
-15.6	48	71	Whole	body	fat	mass	
-15.5	53	71	Android	total	mass	
-15.1	50	73	Weight	
-14.7	44	62	Waist	circumference	
-14.0	37	28	Body	fat	percentage	
-13.1	37	54	Visceral	adipose	tissue	
-12.7	36	70	Hip	circumference	
-11.4	37	50	Body	surface	area	
-10.7	32	37	Basal	metabolic	rate	
	-7.8	21	27	Whole	body	water	mass	
	-7.8	19	26	Total	lean	mass	
		7.1		9	12	SWI	T2*	left	hippocampus	
		6.7		9	13	SWI	T2*	right	hippocampus	
	-6.1	13		9	rfMRI	amplitudes	(ICA100	node	55)	
		5.5		9	21	Impedance	of	whole	body	
	-5.4	19	31	Ribs	bone	mineral	content	
	-5.3		5		7	Snoring	
	-5.2		6	16	High	light	scatter	reticulocytes	count	
	-4.7		8		5	rfMRI	amplitudes	(ICA100	node	43)	
	-4.7		6		6	rfMRI	amplitudes	(ICA100	node	50)	
		4.5		2		4	SWI	T2*	left	amygdala	
	-4.4		6		4	rfMRI	amplitudes	(ICA100	node	54)	
		4.4		1		5	SWI	T2*	right	amygdala	
	-4.3		6		4	rfMRI	amplitudes	(ICA100	node	51)	
	-4.2		3		6	rfMRI	amplitudes	(ICA100	node	46)	
		4.1		5		1	T1	SIENAX	white	normalised	volume	
		4.1		5		1	T1	SIENAX	white	unnormalised	volume	
	-4.0		6		3	rfMRI	amplitudes	(ICA100	node	52)	
	-4.0		3		0	tfMRI	median	zstat	shapes	
	-4.0		1		5	dMRI	TBSS	OD	Inferior	cerebellar	ped	R	
	-4.0	17	27	Trunk	bone	mineral	content	
	-4.0		2		1	Variation	in	diet	
	-4.0		0		5	dMRI	TBSS	OD	Inferior	cerebellar	ped	L	
	-3.9		4		1	rfMRI	amplitudes	(ICA100	node	36)	
	-3.9		4		9	Portion	size	
	-3.9		4		3	rfMRI	amplitudes	(ICA100	node	42)	
		3.9		3		8	Usual	walking	pace	
	-3.9		2		0	tfMRI	90th-percentile	zstat	shapes	
	-3.8		3		4	Time	spent	watching	television	
	-3.7		2		3	Lymphocyte	count	
	-3.6		5		3	rfMRI	amplitudes	(ICA100	node	5)	
		3.6		3		2	T1	SIENAX	brain	normalised	volume	
		3.6		0		0	Forced	vital	capacity	
	-3.6		3		2	rfMRI	amplitudes	(ICA100	node	48)	
	-3.6		2		0	tfMRI	median	zstat	faces	
		3.5		2		9	dMRI	TBSS	L1	Inferior	cerebellar	ped	R	
	-3.5		6		2	rfMRI	amplitudes	(ICA100	node	15)	
	-3.5		6		1	rfMRI	amplitudes	(ICA100	node	38)	
		3.5		3		1	T1	SIENAX	brain	unnormalised	volume	
	-3.5		2	11	dMRI	ProbtrackX	ICVF	Medial	lemniscus	L	
		3.5		2		3	Tea	consumed	
		3.5		1		3	Frequency	of	stair	climbing	in	last	month	
	-3.5		1		0	tfMRI	90th-percentile	zstat	faces	
	-3.4		2		1	rfMRI	connectivity	(ICA100	edge	205)	
	-3.4		3		3	rfMRI	amplitudes	(ICA100	node	22)	
		3.4		2		3	Days	per	week	vigorous	physical	activity	
	-3.4		2	11	dMRI	ProbtrackX	ICVF	Medial	lemniscus	R	
	-3.3		3		7	Diastolic	blood	pressure
a b c
ICA100 network connectivity
ICA100 node amplitudes
ICA100 network connectivity
ICA100 node amplitudes
ICA100 node 
amplitudes
		ICA	%	%raw											CCA-ICA	mode	6	
	-9.6	10		1	Handedness	
		8.1		7		6	Birth	weight	
	-7.4		5		2	rfMRI	connectivity	(ICA100	edge	524)	
	-7.0		4	22	Impedance	of	whole	body	
		6.7		4		2	Breastfed	as	a	baby	
	-6.3		4		2	rfMRI	connectivity	(ICA100	edge	505)	
		6.0		3		1	Duration	of	questionnaire	
		5.4		3		3	Cardiac	index	
		5.4		3	11	rfMRI	amplitudes	(ICA100	node	1)	
	-5.3		3		9	rfMRI	connectivity	(ICA25	edge	157)	
		5.2		3		8	Cardiac	output	
	-5.2		3		3	rfMRI	connectivity	(ICA25	edge	203)	
		5.1		2		2	Frequency	of	heavy	DIY	in	last	4	weeks	
		5.1		3	10	T1	FIRST	brain	stem+4th	ventricle	volume	
		4.8		2	11	rfMRI	amplitudes	(ICA100	node	16)	
		4.7		3	23	Trunk	fat-free	mass	
	-4.7		2		7	Trunk	fat	percentage	
		4.7		2		0	Pulse	rate	
		4.6		2	22	dMRI	TBSS	L1	Sagittal	stratum	R	
		4.6		2	13	rfMRI	amplitudes	(ICA25	node	19)	
		4.5		2		9	rfMRI	amplitudes	(ICA100	node	14)	
	-4.5		2		9	dMRI	TBSS	OD	Sagittal	stratum	R	
	-4.5		2		8	dMRI	ProbtrackX	OD	Parahipp	cingulum	L	
		4.4		2		0	Nucleated	red	blood	cells	percentage	
		4.4		3	14	Hand	grip	strength	(right)	
		4.4		2		2	rfMRI	connectivity	(ICA100	edge	498)	
	-4.4		2		0	rfMRI	connectivity	(ICA100	edge	501)	
		4.4		3	22	Whole	body	fat-free	mass	
	-4.4		2	14	Body	fat	percentage	
		4.4		3	22	Arms	fat-free	mass	
		4.3		1	10	dMRI	ProbtrackX	MD	Acoustic	radiation	L	
	-4.3		2		0	Transport	type	for	commuting	to	job	
	-4.3		2		1	Sleep	duration	
		4.3		2		7	rfMRI	amplitudes	(ICA100	node	4)	
	-4.3		1	18	dMRI	ProbtrackX	OD	inf	long	fasciculus	R	
	-4.3		1		4	rfMRI	connectivity	(ICA25	edge	14)	
		4.3		2		1	Reticulocytes	count	
		4.2		1		1	High	light	scatter	reticulocytes	count	
		4.2		1		8	dMRI	ProbtrackX	L2	Acoustic	radiation	L	
	-4.2		2		7	rfMRI	connectivity	(ICA100	edge	106)	
		4.2		1		1	Average	heart	rate	
		4.2		2		3	Yogurt	intake	
		4.1		2		8	T1	FIRST	left	thalamus	volume	
		4.1		1		0	Heart	rate	during	PWA	
		4.0		1	11	rfMRI	amplitudes	(ICA25	node	2)	
		4.0		1		3	dMRI	ProbtrackX	ISOVF	Acoustic	rad	L	
		4.0		1		3	dMRI	ProbtrackX	FA	Parahipp	cingulum	L	
	-4.0		1		0	dMRI	ProbtrackX	L3	Parahipp	cingulum	L	
	-4.0		2		2	rfMRI	connectivity	(ICA100	edge	509)	
		4.0		1		9	dMRI	ProbtrackX	L1	Acoustic	radiation	L	
		4.0		2		0	Fruit	consumer	
	-4.0		1	16	dMRI	ProbtrackX	OD	Posterior	thal	rad	L	
		4.0		2	16	dMRI	ProbtrackX	L1	Forceps	major	
		4.0		1	16	dMRI	TBSS	L1	Retrolent	internal	capsule	R	
	-3.9		2		2	dMRI	TBSS	OD	Inferior	cerebellar	ped	L	
		3.9		1		0	rfMRI	connectivity	(ICA100	edge	360)	
	-3.9		1		0	Time	spent	watching	television	
		3.9		2		0	rfMRI	connectivity	(ICA100	edge	164)	
		3.9		1		1	Beats	in	waveform	average	for	PWA	
	-3.9		1	15	dMRI	ProbtrackX	OD	Inf	fronto-occ	fasc	R	
	-3.8		2		1	rfMRI	connectivity	(ICA25	edge	191)	
		3.8		1		1	Immature	reticulocytes	fraction	
		3.8		1		0	Platelet	Crit	
		3.8		2		2	rfMRI	connectivity	(ICA100	edge	518)	
		3.8		2		1	Duration	of	walks	
	-3.8		1		9	dMRI	ProbtrackX	OD	Uncinate	fasciculus	L	
	-3.8		1		6	rfMRI	connectivity	(ICA25	edge	165)	
		3.8		1		1	Poultry	intake	
		3.8		1		1	rfMRI	connectivity	(ICA25	edge	110)	
		3.8		1		1	Duration	of	heavy	DIY	
		3.8		2		8	T1	FIRST	right	thalamus	volume	
	-3.8		1		3	dMRI	ProbtrackX	OD	Cing	gyrus	cingulum	R	
	-3.8		1		9	dMRI	ProbtrackX	OD	Parahipp	cingulum	R
		ICA	%	%raw											CCA-ICA	mode	4	
-10.6	22	12	Heart	rate	during	PWA	
-10.5	21	12	Average	heart	rate	
	-9.7	16	34	rfMRI	connectivity	(ICA25	edge	103)	
	-8.9	14	31	rfMRI	connectivity	(ICA25	edge	101)	
		8.8	18	43	rfMRI	amplitudes	(ICA25	node	15)	
		8.5	14	38	rfMRI	amplitudes	(ICA25	node	10)	
		8.4	14	39	rfMRI	amplitudes	(ICA25	node	12)	
	-8.3	13	29	rfMRI	connectivity	(ICA25	edge	148)	
	-8.2	12	26	rfMRI	connectivity	(ICA25	edge	102)	
	-8.0	11	23	rfMRI	connectivity	(ICA25	edge	147)	
		7.8	11	25	rfMRI	connectivity	(ICA25	edge	65)	
		7.6	13	36	rfMRI	amplitudes	(ICA100	node	8)	
		7.5	10	27	rfMRI	connectivity	(ICA25	edge	151)	
		7.4	12	31	rfMRI	amplitudes	(ICA100	node	32)	
	-7.3		9	21	rfMRI	connectivity	(ICA100	edge	429)	
	-7.2	11	25	rfMRI	connectivity	(ICA25	edge	146)	
		7.1	13	30	rfMRI	amplitudes	(ICA100	node	23)	
		7.1	10	23	rfMRI	connectivity	(ICA25	edge	55)	
	-7.0	14	15	Cardiac	output	during	PWA	
		7.0		9	19	rfMRI	connectivity	(ICA25	edge	66)	
		6.9	12	31	rfMRI	amplitudes	(ICA100	node	41)	
		6.7		8	10	Total	peripheral	resistance	during	PWA	
	-6.6		8	22	rfMRI	connectivity	(ICA100	edge	488)	
		6.5		7	17	rfMRI	connectivity	(ICA100	edge	689)	
	-6.4		7	14	rfMRI	connectivity	(ICA25	edge	45)	
		6.4		6	15	rfMRI	connectivity	(ICA100	edge	471)	
		6.4		8	26	rfMRI	amplitudes	(ICA100	node	30)	
	-6.3		7	12	dMRI	ProbtrackX	L1	Corticospinal	tract	R	
	-6.3	13	14	Cardiac	index	during	PWA	
	-6.2		9	17	rfMRI	connectivity	(ICA25	edge	135)	
	-6.0		5	11	dMRI	ProbtrackX	ISOVF	Corticospin	tract	R	
	-5.9		7	16	rfMRI	connectivity	(ICA100	edge	237)	
	-5.9		8	22	rfMRI	connectivity	(ICA100	edge	788)	
	-5.8		1		0	Sitting	height	
	-5.8		5	12	rfMRI	connectivity	(ICA25	edge	153)	
	-5.8		7	13	rfMRI	connectivity	(ICA100	edge	240)	
		5.8		8	23	rfMRI	amplitudes	(ICA25	node	11)	
		5.8		6	13	rfMRI	connectivity	(ICA100	edge	412)	
		5.7		9	29	rfMRI	amplitudes	(ICA25	node	17)	
	-5.7		7	18	rfMRI	connectivity	(ICA100	edge	162)	
		5.7	10	29	rfMRI	amplitudes	(ICA25	node	18)	
	-5.6		7	12	dMRI	ProbtrackX	L1	Corticospinal	tract	L	
	-5.6		6		3	Impedance	of	whole	body	
		5.5		6	16	rfMRI	connectivity	(ICA100	edge	495)	
		5.5		5		5	Legs	lean	mass	
		5.5		5	12	rfMRI	connectivity	(ICA25	edge	38)	
		5.5		7	18	rfMRI	amplitudes	(ICA100	node	9)	
		5.4		4	12	rfMRI	connectivity	(ICA25	edge	186)	
	-5.4		5	15	rfMRI	connectivity	(ICA100	edge	408)	
	-5.4		7		0	Cardiac	output	
	-5.2		1		0	Standing	height	
	-5.2		5	17	rfMRI	connectivity	(ICA25	edge	58)	
		5.2		6	16	rfMRI	connectivity	(ICA25	edge	185)	
	-5.2		6	13	rfMRI	connectivity	(ICA100	edge	698)	
	-5.1		0		1	Forced	vital	capacity	
	-5.0		5	12	rfMRI	connectivity	(ICA25	edge	183)
		ICA	%	%raw											CCA-ICA	mode	5	
-10.0	16		5	SWI	T2*	left	putamen	
	-9.5	14		4	SWI	T2*	right	putamen	
	-8.7	13		5	SWI	T2*	left	caudate	
		8.4	10		4	Mean	Corpuscular	Haemoglobin	
	-7.6	10		5	SWI	T2*	right	caudate	
		7.3		7		2	Mean	Corpuscular	Volume	
		7.1		6		5	Alcohol	intake	frequency	
		6.7		6		2	Smoking	status	
	-6.4	11		3	Cardiac	index	
		6.3		7	31	rfMRI	amplitudes	(ICA25	node	1)	
		6.1		5		1	Past	tobacco	smoking	
		6.1		6	34	rfMRI	amplitudes	(ICA25	node	13)	
	-6.1		8		0	Cardiac	output	
		6.0		6		4	Haemoglobin	Concentration	
	-5.8		8	17	Cardiac	output	during	PWA	
	-5.8		6		4	SWI	T2*	left	thalamus	
		5.7		5		2	Alcohol	consumed	yesterday	
		5.6		6	29	rfMRI	amplitudes	(ICA25	node	9)	
	-5.6		6	16	Peripheral	pulse	pressure	during	PWA	
	-5.6		5		4	SWI	T2*	right	pallidum	
	-5.6		9	17	Cardiac	index	during	PWA	
	-5.5		6		4	SWI	T2*	left	pallidum	
		5.5		6	33	rfMRI	amplitudes	(ICA25	node	21)	
		5.5		5	35	rfMRI	amplitudes	(ICA25	node	6)	
	-5.4		5	14	Stroke	volume	during	PWA	
		5.4		8	31	rfMRI	amplitudes	(ICA100	node	22)	
		5.4		5	34	rfMRI	amplitudes	(ICA25	node	3)	
		5.4		7	38	rfMRI	amplitudes	(ICA100	node	44)	
	-5.2		5	15	Central	pulse	pressure	during	PWA	
		5.1		6	29	rfMRI	amplitudes	(ICA100	node	25)	
		5.1		8	32	rfMRI	amplitudes	(ICA100	node	2)	
	-5.1		3		2	Red	blood	cell	Distribution	Width	
		5.1		6	34	rfMRI	amplitudes	(ICA25	node	16)	
		5.0		6	31	rfMRI	amplitudes	(ICA100	node	33)	
	-5.0		4		3	SWI	T2*	right	thalamus	
	-5.0		6	14	Systolic	brachial	blood	press	during	PWA	
		4.9		7	28	rfMRI	amplitudes	(ICA100	node	13)	
		4.9		5	13	dMRI	TBSS	ICVF	Cerebral	peduncle	L	
		4.9		6	11	Total	peripheral	resistance	during	PWA	
	-4.8		5		5	Systolic	blood	pressure	
		4.8		4	30	rfMRI	amplitudes	(ICA25	node	5)	
		4.8		4		1	Light	smokers,	>100	smokes	in	lifetime	
		4.7		5	29	rfMRI	amplitudes	(ICA100	node	28)	
		4.7		4	26	rfMRI	amplitudes	(ICA25	node	7)	
		4.7		6	22	rfMRI	amplitudes	(ICA100	node	17)	
	-4.6		5	14	Central	systolic	blood	press	during	PWA	
		4.6		5	34	rfMRI	amplitudes	(ICA100	node	18)	
		4.6		6	25	rfMRI	amplitudes	(ICA100	node	48)	
		4.6		5	25	rfMRI	amplitudes	(ICA100	node	10)	
		4.5		5	11	dMRI	TBSS	ICVF	Cerebral	peduncle	R	
	-4.5		2		0	LV	stroke	volume	
		4.4		6	23	rfMRI	amplitudes	(ICA25	node	17)	
		4.4		7	30	rfMRI	amplitudes	(ICA100	node	37)	
		4.4		6	29	rfMRI	amplitudes	(ICA25	node	14)	
		4.3		3		1	Mean	sphered	cells	volume	
		4.3		5	25	rfMRI	amplitudes	(ICA100	node	42)	
		4.3		6	30	rfMRI	amplitudes	(ICA100	node	7)	
		4.3		5	22	rfMRI	amplitudes	(ICA100	node	49)	
		4.3		3		3	Haematocrit	percentage	
		4.3		5	21	rfMRI	amplitudes	(ICA100	node	5)	
	-4.3		0		1	Head	bone	mineral	density	
		4.1		3		0	Age	stopped	smoking	
	-4.1		4		4	dMRI	TBSS	L1	Corticospinal	tract	L	
	-4.0		4		8	dMRI	TBSS	ISOVF	Corticospinal	tract	L	
	-4.0		4	10	dMRI	TBSS	MD	Corticospinal	tract	L
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